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ABSTRACT

Christy, Shannon M., Ph.D., Purdue University, August 2015. Relationships Between
Masculinity Beliefs and Colorectal Cancer Screening in Male Veterans. Major Professor:
Catherine E. Mosher.

Colorectal cancer (CRC) is the third most common cancer diagnosed and the third
most common cause of cancer deaths among men in the United States. Although CRC
screening tests can reduce CRC incidence and mortality, men’s current rates of CRC
screening fall below screening objectives. Results from qualitative studies have suggested
masculinity to be a potential barrier to CRC screening as some men may find endoscopic
screening procedures to breach masculinity norms. In prior studies, masculinity beliefs
have been associated with preventive health behaviors as well as risk behaviors among
men. However, to the author’s knowledge, no other quantitative studies have examined
the relationship between masculinity and CRC screening adherence. The current study
aimed to understand the relationship between three aspects of masculinity (i.e., selfreliance, risk-taking, and heterosexual self-presentation), health beliefs, participant
characteristics, and CRC screening adherence. It was hypothesized that the three aspects
of masculinity would be inversely associated with CRC screening adherence. Data were
collected from 350 men aged 51-75 at average risk for CRC who were accessing primary
care services at a Veterans Affairs Medical Center. Of the 350 consenting individuals,
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data from 327 participants were included in study analyses. Of those 327 participants,
213 individuals were adherent to CRC screening guidelines and the remaining 114 were
non-adherent. Correlational and logistic regression analyses were utilized to examine
associations between aspects of masculinity and CRC screening adherence. Conditional
process analyses were used to examine whether health belief variables (i.e., trust in
physician and cancer fear) mediated the relationships between certain aspects of
masculinity and CRC screening adherence. Next, participant characteristics (i.e., race,
age, and length of relationship between the patient and his primary care provider) were
examined as potential moderators of certain relationships in the models utilizing
conditional process analyses. In addition, a hierarchical logistic regression analysis was
utilized to examine whether the three aspects of masculinity predicted CRC screening
adherence above and beyond the predictive value of variables that have predicted CRC
screening adherence in prior studies (i.e., race, age, education, physician recommending
CRC screening, and family/friend recommending CRC screening). Furthermore, logistic
regression analyses were used to examine the extent to which the three aspects of
masculinity predicted the receipt of stool blood testing and endoscopic screening. Results
suggested that none of the three masculinity variables were significantly associated with
CRC screening adherence. In addition, health beliefs did not mediate the proposed
relationships between aspects of masculinity and CRC screening adherence, and
participant characteristics did not moderate relations between certain mediators and
outcome variables. Potential explanations for study results and future directions are

xiii
discussed. Prospective and longitudinal research studies that recruit participants from
diverse backgrounds are required to better understand relationships among study
variables.

1

BACKGROUND

Introduction
Men’s adherence to masculinity norms has been implicated as a risk factor for
unhealthy behaviors (e.g., drinking to intoxication, having unprotected sex with multiple,
simultaneous partners) and lack of engagement in healthy behaviors (e.g., blood pressure
screening, cholesterol screening, wearing protective clothing while in the sun, receipt of
annual medical and dental exams) (Boman & Walker, 2010; Courtenay, 2000a, 2000b,
2011; Hammond, Matthews, & Corbie-Smith, 2010; Iwamoto, Cheng, Lee, Takamatsu,
& Gordon, 2011; Locke & Mahalik, 2005; Mahalik, Lagan, & Morrison, 2006; Mahalik
et al., 2003; Nicholas, 2000; Pachankis, Westmaas, & Dougherty, 2011; Pleck,
Sonenstein, & Ku, 1993; Wade, 2009). Masculinity has been defined as behaviors,
beliefs, and personality characteristics associated more often with men than women as
well as characteristics and behaviors that society prescribes and reinforces in men
(Thompson, Pleck, & Ferrera, 1992). Rooted in geographical, cultural, and temporal
environments, diverse masculinities have emerged throughout the United States and the
world (Connell, 1995; Courtenay, 2011). Traditional masculinity beliefs and behaviors in
the United States include the sturdy oak (men should be tough, self-reliant, stoic, and
confident), no sissy stuff (men should avoid feminine characteristics and behaviors), the
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big wheel (men should strive for success and status), and give ‘em hell (men should
embrace aggressiveness, daring, and violence) (Brannon, 1976).
Numerous qualitative studies have suggested that some men find cancer screening
examinations involving the rectum (i.e., endoscopy for colorectal cancer [CRC] screening
or digital rectal examination [DRE] for prostate cancer screening) an affront to their
masculinity (see Table 1 for quotations from these studies) (Bass et al., 2011; Beeker,
Kraft, Southwell, & Jorgensen, 2000; Getrich et al., 2012; Goldman, Diaz, & Kim, 2009;
Harvey & Alston, 2011; Holt et al., 2009; Jilcott Pitts et al., 2013; Jones, Devers, Kuzel,
& Woolf, 2010; Rivera-Ramos & Buki, 2011; Thompson, Reeder, & Abel, 2011;
Wackerbarth, Peters, & Haist, 2005; Winterich et al., 2009). However, to the author’s
knowledge, no quantitative studies have considered the role of masculinity in CRC
screening adherence. Unfortunately, current CRC screening rates fall below the 70.5%
Healthy People 2020 screening objective (U.S. Department of Health and Human
Services, 2012).
Research is needed to better understand relationships between men’s masculinity
norms and CRC screening adherence so that interventions may be developed to reduce
barriers to screening, improve screening rates, and, ultimately, decrease men’s mortality
from CRC. The present study will address this gap in the literature by examining the
masculinity norms and CRC screening adherence of male veterans aged 51-75 years who
are at average CRC risk (Levin et al., 2008). First, the prevalence of CRC, its risk factors
and warning signs as well as CRC screening techniques, screening rates, and
characteristics of individuals who are adherent and non-adherent to CRC screening
guidelines are summarized. Next, the concept of masculinity, theoretical and empirical
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support for studying masculinity norms within the context of CRC screening, and
potential relationships between masculinity norms and colorectal cancer screening
behaviors are described. Finally, the study methods, results, and future directions and
limitations of this research are described.

Colorectal Cancer: Prevalence, Risk Factors, and Warning Signs
As the third most common cancer diagnosed and the third most common cause of
cancer deaths among men in the United States, CRC represents a significant public health
issue (American Cancer Society, 2014a, 2014b). Compared to women, men are at higher
risk of being diagnosed with CRC and dying from CRC (Howlader et al., 2011). From
2007-2011, 50.6 per 100,000 men received a CRC diagnosis per year and 19.6 per
100,000 men died from CRC per year, whereas 38.2 per 100,000 women received a CRC
diagnosis per year and 13.9 per 100,000 women died from CRC per year (National
Cancer Institute, 2014). Unfortunately, 60% of CRC cases are diagnosed at an advanced
stage (American Cancer Society, 2011, 2014a). It is projected that 132,700 individuals in
the United States will receive a CRC diagnosis (69,090 men and 63,610 women), and
49,700 individuals will die from colon or rectal cancers (26,100 men and 23,600 women)
in 2015 (American Cancer Society, 2015).
A number of risk factors for CRC have been identified (National Cancer Institute,
2012b). Unmodifiable risk factors for CRC include age, family history of CRC, personal
history of precancerous colon polyps, and certain medical conditions (e.g., ulcerative
colitis, Crohn’s disease, CRC-linked hereditary syndromes) (National Cancer Institute,
2012b). Modifiable risk factors for the disease include obesity, smoking, greater alcohol
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intake, lack of physical activity, poor diet, and failure to undergo CRC screening
(National Cancer Institute, 2012b).
A variety of symptoms may be indicative of CRC (National Cancer Institute,
2012a, 2012c). Although many cases of CRC are asymptomatic, when present, common
CRC symptoms include blood in the stool, abdominal pain or bloating, narrowing of
stool, constipation, diarrhea, tenesmus (the sensation that one cannot completely empty
one’s bowels), or other changes in bowel habits (National Cancer Institute, 2012a,
2012c). Other symptoms of CRC include fatigue, vomiting, sudden, unintentional weight
loss, and a change in one’s appetite (National Cancer Institute, 2012a, 2012c).

Screening for Colorectal Cancer
Adherence to CRC screening guidelines by eligible U.S. adults has the potential
to reduce mortality from the disease by approximately half (Brenner, Chang-Claude,
Seiler, Rickert, & Hoffmeister, 2011; Cafferty, Sasieni, & Duffy, 2009; Citarda,
Tomaselli, Capocaccia, Barcherini, & Crespi, 2001; Edwards et al., 2010; Levin et al.,
2008; National Cancer Institute, 2000; Thiis-Evensen et al., 1999; Winawer et al., 1997).
Tests used to identify CRC include colonoscopy, fecal occult blood test (FOBT), fecal
immunochemical test (FIT), barium enema, flexible sigmoidoscopy, DRE, virtual
colonoscopy, biopsy, or carcinoembryonic antigen (CEA) assay, a blood test to detect a
CRC-associated antigen (National Cancer Institute, 2012a, 2012c). CRC is highly
curable when detected early (American Cancer Society, 2012b; National Cancer Institute,
2012d). In addition, some CRC screening methods can remove precancerous colon
polyps before they develop into CRC, thereby decreasing incidence and mortality from
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this disease (American Cancer Society, 2012b; Brenner et al., 2011; Cafferty et al., 2009;
Citarda et al., 2001; Edwards et al., 2010; Levin et al., 2008; National Cancer Institute,
2000, 2012d; Thiis-Evensen et al., 1999; Winawer et al., 1997).
Recommended CRC screening methods vary according to one’s risk factors for
the disease. These risk factors include increasing age, family history of CRC, a history of
colon polyps, genetic syndromes (e.g., familial adenomatous polyposis, Lynch
syndrome), and certain medical conditions (e.g., ulcerative colitis, Crohn’s disease)
(Levin et al., 2008). Individuals who lack risk factors other than age are at average risk
for CRC (Levin et al., 2008). For these individuals, screening begins at age 50 and
includes the following six options: (1) single-strand DNA (frequency not specified); (2)
FOBT or FIT each year; (3) flexible sigmoidoscopy every five years; (4) double-contrast
barium enema every five years; (5) virtual colonoscopy every five years; or (6)
colonoscopy every ten years (Levin et al., 2008; Smith, Cokkinides, Brooks, Saslow, &
Brawley, 2010). Among individuals at increased risk for CRC, colonoscopy is
recommended for CRC surveillance and this test may begin prior to age 50 (Smith et al.,
2010). Despite a range of CRC screening options for average-risk individuals, only
60.2% of American men aged 50 or older are adherent to current CRC screening
recommendations (American Cancer Society, 2014b).

Characteristics Associated with Colorectal Cancer Screening Adherence and
Non-adherence
A number of demographic, personal health, and clinical variables have been
associated with CRC screening in men and women (Beydoun & Beydoun, 2008; Brouse,
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Wolf, & Basch, 2008; Centers for Disease Control and Prevention, 2012b; Farmer,
Bastani, Kwan, Belman, & Ganz, 2008; Friedman, Webb, & Everett, 2004; Guessous et
al., 2010; Honda, 2004; Jandorf et al., 2010; Kremers, Mesters, Pladdet, van den Borne,
& Stockbrugger, 2000; Post et al., 2008; Tabbarah, Nowalk, Raymund, Jewell, &
Zimmerman, 2005; Tessaro, Mangone, Parkar, & Pawar, 2006; Vernon, 1997; Ziegler,
Schubring-Giese, Buhner, & Kolligs, 2010). Prior research has consistently found that
White race and older age (65 years and older) predict CRC screening (Centers for
Disease Control and Prevention, 2012b). Additional predictors of CRC screening
adherence include male gender, greater income, higher educational attainment, health
insurance coverage, being married, physician recommendation, a family history of CRC,
perceived family/friend support for CRC screening, adherence to other cancer screening
guidelines and health protective behaviors, more frequent health care visits, and a
preventive health orientation (Beydoun & Beydoun, 2008; Brouse et al., 2008; Centers
for Disease Control and Prevention, 2012b; Farmer et al., 2008; Friedman et al., 2004;
Guessous et al., 2010; Honda, 2004; Jandorf et al., 2010; Kremers et al., 2000; Post et al.,
2008; Tabbarah et al., 2005; Tessaro et al., 2006; Vernon, 1997; Ziegler et al., 2010).
Mixed associations have been obtained between medical co-morbidities and CRC
screening (Fleming, Schoenberg, Tarasenko, & Pearce, 2011; Lukin et al., 2012).
Although male gender has predicted CRC screening in prior studies, researchers have
found that men’s self-reported colonoscopy rates were inflated and that over-reporting of
colonoscopy by men may in fact account for the gender differences in CRC screening
rates found in these studies (Griffin et al., 2009).
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Cognitive variables also have been predictive of CRC screening behavior. For
example, perceived risk of CRC and self-efficacy for CRC screening test completion
have been positively associated with CRC screening adherence (Halbert et al., 2011;
Kremers et al., 2000; Myers et al., 1994; Tessaro et al., 2006). However, the relationship
between perceived risk of CRC and CRC screening has been inconsistent (Manne et al.,
2003). Lack of knowledge of both CRC and CRC screening also has been associated
with decreased CRC screening (Beeker et al., 2000; Berkowitz, Hawkins, Peipins, White,
& Nadel, 2008; Friedemann-Sanchez, Griffin, & Partin, 2007; Jones, Devers, et al., 2010;
Jones, Woolf, et al., 2010; O'Malley, Beaton, Yabroff, Abramson, & Mandelblatt, 2004).
In addition, CRC test requirements (e.g., collecting stool samples, test preparation for
endoscopy, including food restriction and consuming the preparation laxative) have been
noted as perceived barriers to CRC screening (Beeker et al., 2000; Denberg et al., 2005;
Jones, Devers, et al., 2010). Low health literacy, greater cancer fatalism, and lack of trust
in one’s physician also have been associated with decreased CRC screening adherence
(Jones, Devers, et al., 2010; O'Malley et al., 2004; Shelton, Jandorf, Ellison, Villagra, &
DuHamel, 2011).
A growing body of research has examined the role of affect and emotions in CRC
screening behavior (Consedine, Magai, Krivoshekova, Ryzewicz, & Neugut, 2004;
Consedine, Reddig, Ladwig, & Broadbent, 2011; Manne et al., 2003; Paddison & Yip,
2010; Power et al., 2008; Rawl, Menon, Champion, Foster, & Skinner, 2000; Robinson et
al., 2011; Sandberg & Conner, 2009; Waller, Bartoszek, Marlow, & Wardle, 2009). Fear
of cancer and fear of pain related to screening have been inversely related to CRC
screening (Farraye et al., 2004; Feeley, Cooper, Foels, & Mahoney, 2009; Friedemann-
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Sanchez et al., 2007; Jandorf et al., 2010; Jones, Devers, et al., 2010; Weinberg, Turner,
Wang, Myers, & Miller, 2004). In addition, concern about one’s body being exposed to
others and negative attitudes toward CRC screening tests and test preparation have been
found to be negatively associated with screening (Beeker et al., 2000; Denberg et al.,
2005; Farraye et al., 2004; Feeley et al., 2009; Friedemann-Sanchez et al., 2007; Janz,
Wren, Schottenfeld, & Guire, 2003; Jones, Devers, et al., 2010; Jones, Woolf, et al.,
2010). Greater embarrassment has been consistently associated with both lower stage of
readiness to complete CRC screening and decreased CRC screening behaviors
(Consedine, Ladwig, Reddig, & Broadbent, 2011; Paddison & Yip, 2010; Rawl et al.,
2000). On the other hand, anticipated regret (i.e., regret if one were to forgo CRC
screening and later developed CRC) and cancer-related worry have been positively
related to intentions to complete CRC screening (Brenes & Paskett, 2000; Ferrer et al.,
2011; Power et al., 2008; Wardle et al., 2000). Whereas anticipated regret has been
unrelated to CRC screening behavior (Power et al., 2008), cancer-related worry has
shown negative associations with this behavior (Robinson et al., 2011).
Although researchers have identified demographic, cognitive, and affective
factors as predictors of CRC screening behavior, these studies have failed to examine the
potential role of masculinity norms in men’s screening behavior. Although not yet tested,
a conceptual framework which integrates previously demonstrated predictors of CRC
screening behavior (e.g., demographics, cognitions, emotions), physician and systemslevel characteristics, and aspects of masculinity and gender role beliefs has been created
(Christy, Mosher, & Rawl, 2014). Even though qualitative studies have shown that some
men believe that cancer screening involving the rectum violates masculinity norms (Bass
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et al., 2011; Beeker et al., 2000; Getrich et al., 2012; Goldman et al., 2009; Harvey &
Alston, 2011; Holt et al., 2009; Jilcott Pitts et al., 2013; Jones, Devers, et al., 2010;
Rivera-Ramos & Buki, 2011; Thompson et al., 2011; Wackerbarth et al., 2005; Winterich
et al., 2009), to the author’s knowledge, no quantitative examination of the role of
masculinity norms in CRC screening adherence has been conducted.

Masculinity
Masculinity has been conceptualized as male characteristics based on commonly
found differences between males and females as well as the characteristics that society
imposes and emphasizes in males (Thompson et al., 1992). In the United States, there are
various types of masculinities that are adopted by diverse groups of men (e.g., based
upon sexual orientation, geographic region, race, socioeconomic status, time period)
(Campbell & Bell, 2000; Courtenay, 2011; Levant, Majors, & Kelley, 1998). However,
most American conceptualizations of traditional masculinity norms include the following
ideals: emotional control, non-relational attitudes toward sexuality, power over women,
winning, dominance, primacy of work, avoidance of femininity, pursuit of status,
violence/aggression, risk-taking, self-reliance, and disdain for gay individuals (or
heterosexual self-presentation) (Brannon, 1976; Mahalik et al., 2003; Parent & Moradi,
2009; Walker, Tokar, & Fischer, 2000). Gender role conflict (or stress) occurs when a
man who holds masculinity beliefs is confronted by a situation in which those
masculinity beliefs are or may be breached (Eisler, Skidmore, & Ward, 1988; O'Neil,
2008). Gender role conflict and adherence to masculinity norms have been found to vary
as a function of race and socioeconomic status (SES) (Abreu, Goodyear, Campos, &
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Newcomb, 2000; Connell, 1995; Courtenay, 2011; Courtenay, 2000a; Jakupcak, Lisak, &
Roemer, 2002; Levant & Majors, 1997; Levant et al., 1998; Levant et al., 2003; Mahalik
et al., 2003; Norwalk, Vandiver, White, & Englar-Carlson, 2011; Stillson, O'Neil, &
Owen, 1991). Specifically, African-American and Hispanic men generally have reported
higher levels of gender role conflict and traditional masculinity norms compared to
Caucasian men (Abreu et al., 2000; Levant & Majors, 1997; Levant et al., 1998; Norwalk
et al., 2011). In addition, men from lower SES backgrounds are more likely than those of
higher SES to adhere to traditional masculinity norms and experience gender role conflict
(Connell, 1995; Courtenay, 2000a, 2011; Mahalik et al., 2003; Stillson et al., 1991).
Masculinity beliefs have been predictive of perceived barriers to health care use
and degree of engagement in health-promoting behaviors (Boman & Walker, 2010;
Courtenay, 2000a, 2000b, 2011; Mahalik & Burns, 2011; Mahalik, Burns, & Syzdek,
2007; Nicholas, 2000; Pleck et al., 1993; Springer & Mouzon, 2011). Men who endorse
higher levels of masculinity have been found to be less likely to engage in preventive
health care (e.g., prostate cancer examination, flu shot) compared to men with moderate
levels of masculinity (Springer & Mouzon, 2011). In addition, endorsement of
masculinity norms, coupled with higher levels of perceived barriers to performance of
heart-healthy behaviors (e.g., healthy diet, regular exercise, medical check-ups and tests),
have been associated with decreased likelihood of performing these behaviors (Mahalik
& Burns, 2011).
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Evidence for the Role of Masculinity in CRC Screening
Although no known quantitative research has been conducted to examine the
relationship between masculinity norms and CRC screening adherence, qualitative
evidence supports the possibility that adherence to masculinity norms may influence
some men’s willingness to undergo endoscopic CRC screening (see Table 1) (Bass et al.,
2011; Beeker et al., 2000; Getrich et al., 2012; Goldman et al., 2009; Harvey & Alston,
2011; Holt et al., 2009; Jilcott Pitts et al., 2013; Jones, Devers, et al., 2010; RiveraRamos & Buki, 2011; Thompson et al., 2011; Wackerbarth et al., 2005; Winterich et al.,
2009). For example, an African-American man reported “…probing around in my
rectum . . . [is] treading on my masculinity” (Beeker et al., 2000, p. 268). Similarly,
another African-American man stated “…biggest fear…someone placing something in
my rectum, that’s how most men are” (Winterich et al., 2009, p. 6). When describing a
friend who had undergone CRC screening, a Hispanic man reported “[My friend] told me
he had lost his manhood. So, we must be very careful with that because people think that
they lose their manhood” (Jones, Devers, et al., 2010, p. 512). Yet another man asserted
“I think it’s problematic for men…especially homophobic men…they think you let
someone do that to you, you ain’t a real man” (Jones, Devers, et al., 2010, p. 512).
Identifying colonoscopy specifically, one man noted “…you know, guys are usually
reluctant to have colonoscopies because I guess it is a male ego thing you know, having
something inserted into your rectum” (Bass et al., 2011, p. 124). These quotations
highlight themes of masculinity that have been revealed by a number of men in
qualitative studies on CRC screening.
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A few quantitative studies of cancer screening and prevention have broached the
topics of masculinity and/or concerns about screening involving the rectum (Jones,
Devers, et al., 2010; Millar & Houska, 2007; Paiva, Motta, & Griep, 2011). In a study of
intention to perform self-examination for skin cancer, men and women with low levels of
masculinity were more likely to report intention to perform the behavior than those with
high levels of masculinity (Millar & Houska, 2007). To this author’s knowledge, only
one quantitative study has evaluated the role of masculinity in cancer screening involving
the rectum (Paiva et al., 2011). This study focused on prostate cancer screening and used
a single item to assess perceptions of masculinity with respect to prostate cancer
screening (Paiva et al., 2011). Researchers found that more than one-third of participants
reported they agreed with the following statement: “the prostate examination can affect
masculinity” (34.4%) (Paiva et al., 2011). In a study of CRC screening decision-making
among both men and women, the statement “I do not want a tube inserted in my rectum”
was ranked as one of the top five barriers to colonoscopy and sigmoidoscopy (Jones,
Devers, et al., 2010). This statement was the top-ranked barrier for those who had never
been screened and was ranked second by those overdue for screening (Jones, Devers, et
al., 2010). However, it is unclear whether masculinity beliefs influenced men’s decisions
regarding CRC screening (Jones, Devers, et al., 2010).

Proposed Relationships between Aspects of Masculinity and Colorectal Cancer Screening
Given that some men have voiced concerns that cancer screening tests involving
the rectum (i.e., endoscopy, DRE) are an affront to masculinity norms (Bass et al., 2011;
Beeker et al., 2000; Getrich et al., 2012; Goldman et al., 2009; Harvey & Alston, 2011;
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Holt et al., 2009; Jilcott Pitts et al., 2013; Jones, Devers, et al., 2010; Rivera-Ramos &
Buki, 2011; Thompson et al., 2011; Wackerbarth et al., 2005; Winterich et al., 2009), it
was proposed that three masculinity norms (i.e., heterosexual self-presentation, risktaking, and self-reliance) would be inversely related to CRC screening adherence among
men at average CRC risk. First, it was hypothesized that heterosexual self-presentation
would be inversely related to CRC screening adherence. According to masculinity theory
(Brannon, 1976; Courtenay, 2011), masculine, heterosexual men should disdain
homosexuality, fear gay individuals (especially gay men), and preserve their own
heterosexuality. Qualitative research supports this notion with men emphasizing their
concern that cancer screening involving the rectum could affect their sexuality or be
indicative of homosexuality (Getrich et al., 2012; Harvey & Alston, 2011; Holt et al.,
2009; Jones, Devers, et al., 2010; Thompson et al., 2011; Winterich et al., 2011). If a
man visits his provider and receives a CRC screening recommendation, colonoscopy is
the most likely test to be recommended (Klabunde et al., 2009; McQueen et al., 2009). It
is unlikely that a patient will be fully informed about all screening test options (Klabunde
et al., 2009; McQueen et al., 2009), and those men who would be more comfortable with
FOBT or FIT (i.e., men adhering to the heterosexual self-presentation masculinity norm)
may go unscreened if only offered screening methods involving penetration of the rectum
(McQueen et al., 2009).
Second, it was hypothesized that the masculinity norm of risk-taking would be
inversely related to CRC screening adherence. Endorsement of the risk-taking
masculinity norm has been associated with performance of risky health behaviors (e.g.,
smoking, drinking to intoxication) (Mahalik et al., 2003), but has not been examined with
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regard to CRC screening adherence. According to masculinity theory (Courtenay, 2000a,
2000b, 2011; Nicholas, 2000), men who hold risk-taking beliefs may not feel that CRC or
other diseases are a threat to their well-being. In addition, masculinity theory suggests
that these individuals may not be concerned about their health, attend preventive health
services, or undergo CRC screening (Courtenay, 2000a, 2000b, 2011; Nicholas, 2000).
For example, a study of skin cancer reduction behaviors (i.e., sunscreen usage and skin
self-examination) included a masculinity measure with an item addressing risk-taking
beliefs (Bem, 1974; Millar & Houska, 2007). The results of this study indicated that
individuals endorsing higher levels of masculinity were: 1) less likely to report distress
about skin cancer risks and 2) more likely to report being in better health compared to
individuals with lower levels of masculinity beliefs (Millar & Houska, 2007).
Furthermore, individuals reporting higher levels of masculinity reported lower levels of
intention to engage in skin cancer self-examination (Millar & Houska, 2007).
In the current study, it was hypothesized that the relationship between risk-taking
and CRC screening adherence would be partially mediated by cancer fear. Specifically,
based on masculinity theory (Courtenay, 2000a, 2000b, 2011), it was predicted that
greater risk-taking would be associated with lower levels of cancer fear, which, in turn,
would be associated with a lower likelihood of CRC screening adherence. According to
masculinity theory (Courtenay, 2000a, 2000b, 2011; Nicholas, 2000), masculinity ideals
such as risk-taking bolster the belief that men should deny vulnerability to diseases.
Thus, the theory predicts an inverse association between risk-taking beliefs and cancer
fear. Additionally, in a study of prostate cancer screening, trait fear was positively
associated with screening behavior (Consedine, Morgenstern, Kudadjie-Gyamfi, Magai,
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& Neugut, 2006). Prior research has demonstrated mixed results with regard to the
relationship between cancer fear and cancer screening in primarily female samples
(Consedine et al., 2004; Hay, Buckley, & Ostroff, 2005). However, in a review of the
literature on breast cancer screening, Consedine and colleagues (2004) found that general
cancer fear may be associated with increases in cancer screening, whereas fear of specific
aspects of screening or the specific disease type (e.g., belief that screening is painful or
embarrassing, fears of specific cancer treatments if diagnosed with cancer) are inversely
associated with cancer screening. These researchers suggested that “acting to reduce
generalized cancer worry may, in many cases, involve engaging in a screening behavior
as the individual seeks to reduce their anxiety” (Consedine et al., 2004, p. 507). In the
present study, general cancer fear was measured and, therefore, a positive association
between cancer fear and CRC screening adherence was hypothesized.
It was also hypothesized that age would moderate the strength of the relationship
between cancer fear and CRC screening adherence such that the relationship between
cancer fear and CRC screening would be weaker with increasing age. In studies of
cancer survivors, age has been inversely related to fear of cancer recurrence (Crist &
Grunfeld, 2013; Lebel, Beattie, Arès, & Bielajew, 2013; Ziner et al., 2012). Additionally,
increasing age has been found to be inversely related to fear of death (Cicirelli, 2006).
Furthermore, in a study of adult women aged 30 to 74, older women reported less breast
cancer worry than younger women (Harris et al., 1991). Thus, although the current study
was focused upon men, increasing age was predicted to be inversely related to fear of
cancer, rendering it a weak predictor of CRC screening in older age groups.
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Third, it was hypothesized that self-reliance would be inversely related to CRC
screening adherence. Masculinity theory suggests that men who endorse self-reliance
ideals may not have a consistent health care provider and, therefore, may not have an
opportunity to receive a recommendation for CRC screening (Boman & Walker, 2010;
Courtenay, 2000a, 2000b, 2011; Hammond, Matthews, & Corbie-Smith, 2010; Iwamoto
et al., 2011; Locke & Mahalik, 2005; Mahalik et al., 2006; Mahalik et al., 2003;
Nicholas, 2000; Pachankis et al., 2011; Pleck et al., 1993; Wade, 2009). These
individuals may not believe that “real men” see primary care providers (PCPs) for
preventive care or undergo cancer screening. Indeed, individuals who endorse selfreliance ideals may not trust physicians due to the belief that one should not ask for help
and their infrequent interactions with health care providers. Lack of trust in one’s
physician and the medical system has been indicated as a barrier to CRC screening and
other preventive health services, especially among individuals from ethnic minority
groups (Fyffe, Hudson, Fagan, & Brown, 2008; Greiner, Born, Nollen, & Ahluwalia,
2005; Hammond, Matthews, Mohottige, Agyemang, & Corbie-Smith, 2010; Jones,
Devers, et al., 2010). Thus, it was hypothesized that the relationship between selfreliance and CRC screening adherence would be partially mediated by trust in PCP.
Specifically, it was expected that greater self-reliance would be associated with lower
levels of trust in PCP, which, in turn, would be associated with a lower likelihood of
CRC screening adherence.
Length of patient-provider relationship and race were hypothesized to influence
the relationship between trust in one’s physician and CRC screening adherence. From a
theoretical standpoint, trust in PCP has been conceptualized as stemming from both
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interpersonal trust through multiple interactions with a PCP as well as social trust which
includes trust of healthcare institutions (Pearson & Raeke, 2000). Described as “patient
trust theory,” patients’ trust in their PCP is “built through repeated interactions through
which expectations about a person's trustworthy behavior can be tested over time”
(Pearson & Raeke, 2000, p. 510). Length of the patient-provider relationship has been
positively correlated with trust in PCP (r = 0.27) (Kao, Green, Davis, Koplan, & Cleary,
1998; Mainous, Baker, Love, Gray, & Gill, 2001). In addition, trust in PCP has been
predictive of the receipt of preventive health services (i.e., mammography, flu vaccine,
eye examination) (Parchman & Burge, 2004). Furthermore, ethnic minority patients have
been found to report lower levels of trust in PCPs relative to White patients (Boulware,
Cooper, Ratner, LaVeist, & Powe, 2003; Doescher, Saver, Franks, & Fiscella, 2000;
Halbert, Armstrong, Gandy, & Shaker, 2006; Musa, Schulz, Harris, Silverman, &
Thomas, 2009). In one study, race (African American vs. White) and trust in PCP did not
interact to predict receipt of prostate-specific antigen tests (Musa et al., 2009). However,
as indicated by ethnic minority men in numerous qualitative studies of cancer screenings
involving the rectum, endoscopic CRC screening was considered to be invasive and an
affront to masculinity norms (Bass et al., 2011; Beeker et al., 2000; Getrich et al., 2012;
Harvey & Alston, 2011; Holt et al., 2009; Rivera-Ramos & Buki, 2011; Winterich et al.,
2011; Winterich et al., 2009). Therefore, trust in PCP may be especially important in
overcoming these barriers to CRC screening among ethnic minority men. Thus, it was
hypothesized that race and length of patient-provider relationship would moderate the
strength of the relationship between trust in PCP and CRC screening adherence.
Specifically, it was expected that the relationship between trust in PCP and CRC
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screening would be stronger among African Americans compared to Whites and with
increasing length of patient-provider relationship.
As previously noted, endoscopic screening (i.e., colonoscopy, sigmoidoscopy)
may be difficult for some men due to the perceived breach of masculinity norms (Bass et
al., 2011; Beeker et al., 2000; Getrich et al., 2012; Goldman et al., 2009; Harvey &
Alston, 2011; Holt et al., 2009; Jilcott Pitts et al., 2013; Jones, Devers, et al., 2010;
Rivera-Ramos & Buki, 2011; Thompson et al., 2011; Wackerbarth et al., 2005; Winterich
et al., 2009). Due to the invasive nature of endoscopic procedures, masculinity variables
may be differentially associated with stool blood test (e.g., FOBT or FIT) versus
endoscopic screening modalities (i.e., sigmoidoscopy or colonoscopy). Men perceive
colonoscopy to be more invasive than sigmoidoscopy (Friedemann-Sanchez et al., 2007).
Although colonoscopy is a commonly-used method of CRC screening at the proposed
setting of this study (Roudebush Veterans Affairs Medical Center [VAMC] in
Indianapolis, Indiana), few patients at Roudebush VAMC currently receive
sigmoidoscopy (Rao, personal communication, January 18, 2013). Due to the invasive
nature of sigmoidoscopy and colonoscopy, these two screening modalities were
combined into a single outcome of “endoscopy.” Due to the non-invasive nature and
identical testing schedules of FOBT and FIT, these two stool blood tests were combined
into a single outcome of “stool blood test.” In the present study, CRC screening
adherence was considered as both a combined and separate outcome (i.e., adherence to
stool blood test [FOBT or FIT] or endoscopy [sigmoidoscopy in the past 5 years or
colonoscopy in the past 10 years]).
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PRESENT STUDY

The current study aims to understand associations between aspects of masculinity,
health beliefs, and CRC screening adherence in 350 male Veterans Affairs (VA) primary
care patients aged 51-75 years with average CRC risk. This study targeted adult males
who were age-appropriate and at average risk for CRC, including stool blood test (FOBT
or FIT) or endoscopy (sigmoidoscopy or colonoscopy) procedures (Levin et al., 2008).
The setting of the Roudebush VAMC in Indianapolis, Indiana was selected, as there are a
large number of men utilizing primary care at this setting who have access to stool blood
test (FOBT or FIT) and endoscopy (sigmoidoscopy or colonoscopy) services regardless
of health insurance status. Colonoscopy, FOBT, and sigmoidoscopy are the most
commonly utilized screening modalities in the national VA Health Administration (Long
et al., 2012). In addition, since 2005, VA hospitals across the country have attempted to
increase CRC screening among veterans as part of a CRC diagnosis and care quality
improvement strategy (Jackson et al., 2010).
In a recent study considering data from more than 36,000 veterans nationwide,
more than 80% of eligible veterans were adherent to CRC screening recommendations
(Long et al., 2012). Of those veterans adherent to current CRC screening
recommendations, nearly 72% received colonoscopy in the past 10 years, 24% completed
FOBT in the past year, and nearly 4% received sigmoidoscopy in the past 5 years (Long
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et al., 2012). The Roudebush VAMC has CRC screening rates slightly lower than
national VA Health Administration rates; however, these screening rates are still higher
than the CRC screening adherence rates found in the general United States population
(Haggstrom, personal communication, November 1, 2012). Given that unscreened VA
patients have access to CRC screening services and are likely to have received a
recommendation for CRC screening from their PCP, they are an especially unique
population to study.
Primary Objectives. The aims and hypotheses of the present study are as follows:
Aim 1: Examine the extent to which three aspects of masculinity (i.e., heterosexual selfpresentation, risk-taking, and self-reliance) are associated with CRC screening adherence
(i.e., stool blood test [FOBT or FIT] in the past year or endoscopy [i.e., sigmoidoscopy in
the past 5 years or colonoscopy in the past 10 years]) in male VA primary care patients
aged 51-75 while controlling for age, race, and education level.
Hypothesis 1.1: Controlling for age, race, and education level, three aspects of
masculinity (i.e., heterosexual self-presentation, risk-taking, and self-reliance)
will be inversely associated with CRC screening adherence (i.e., stool blood test
[FOBT or FIT] in the past year or endoscopy [sigmoidoscopy in the past 5 years
or colonoscopy in the past 10 years]).
Aim 2: Examine potential mediators of the relationship between aspects of masculinity
(i.e., risk-taking and self-reliance) and CRC screening adherence (i.e., stool blood test
[FOBT or FIT] in the past year or endoscopy [sigmoidoscopy in the past 5 years or
colonoscopy in the past 10 years]) in male VA primary care patients aged 51-75 while
controlling for age, race, and education level.
Hypothesis 2.1: Controlling for age, race, and education level, cancer fear will
partially mediate the relationship between risk-taking and CRC screening
adherence (i.e., stool blood test [FOBT or FIT] in the past year or endoscopy
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[sigmoidoscopy in the past 5 years or colonoscopy in the past 10 years]) in male
VA primary care patients aged 51-75.
Hypothesis 2.2: Controlling for age, race, and education level, trust in PCP will
partially mediate the relationship between self-reliance and CRC screening
adherence (i.e., stool blood test [FOBT or FIT] in the past year or endoscopy
[sigmoidoscopy in the past 5 years or colonoscopy in the past 10 years]) in male
VA primary care patients aged 51-75.
Aim 3: Examine potential moderators of relationships specified in the models proposed in
Aim #2 while controlling for demographic covariates.
Hypothesis 3.1: Controlling for race and education level, age will moderate the
strength of the relationship between cancer fear and CRC screening adherence
such that the relationship between cancer fear and CRC screening will be weaker
with increasing age.
Hypothesis 3.2: Controlling for age and education level, race will moderate the
strength of the relationship between trust in PCP and CRC screening adherence
such that the relationship between trust in PCP and CRC screening will be
stronger among African Americans compared to Whites.
Hypothesis 3.3: Controlling for age, race, and education level, length of patientprovider relationship will moderate the strength of the relationship between trust
in PCP and CRC screening adherence such that the relationship between trust in
PCP and CRC screening will be stronger with increasing length of patientprovider relationship.
Aim 4: Examine the extent to which three aspects of masculinity (i.e., heterosexual selfpresentation, risk-taking, and self-reliance) are associated with CRC screening behavior,
controlling for the effects of variables recognized as significant predictors of CRC
screening in prior research (i.e., White race, older age, higher education level, physician
recommending CRC screening, family and friends recommending CRC screening).
Hypothesis 4.1: Aspects of masculinity (i.e., heterosexual self-presentation, risktaking, and self-reliance) will predict CRC screening adherence above and
beyond the predictive value of race, age, education, physician recommending
CRC screening, and family/friend recommending CRC screening.
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Aim 5: Examine associations between three aspects of masculinity (i.e., heterosexual
self-presentation, risk-taking, and self-reliance) and CRC screening status (i.e., nonadherence, adherence with stool blood test [FOBT or FIT in the past year], or adherence
with endoscopy [sigmoidoscopy in the past 5 years or colonoscopy in the past 10 years])
in male VA primary care patients aged 51-75 while controlling for age, race, and
education level.
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METHODS

Participant Selection
A sample of 350 male veterans who were at average CRC risk and receiving care
at the Roudebush VAMC in primary care clinics were enrolled in the study. Eligibility
criteria included male gender, age 51-75, average CRC risk (i.e., no prior colon or rectal
cancer diagnoses or diagnoses of a medical condition which would place the individual at
increased risk for CRC such as Crohn’s disease, ulcerative colitis, familial adenomatous
polyposis, or Lynch syndrome based upon self-report and medical record review, and no
prior CRC diagnoses in two or more first-degree relatives or in a first-degree relative
prior to age 60 based upon self-report and medical record review), able to read and write
in English, no serious cognitive impairment, and scheduled for an upcoming appointment
in the primary care clinic with either a PCP (e.g., physician or nurse practitioner) or a
registered nurse (RN).
Two hundred and thirty-three of the study participants (67%) were adherent to
CRC screening recommendations (i.e., had a stool blood test [FOBT or FIT] in the past
year, a sigmoidoscopy in the past 5 years, or a colonoscopy in the past 10 years), and 117
were non-adherent to these recommendations. Originally, the dissertation proposal had
specified that 150 individuals would be adherent to CRC screening recommendations and
150 individuals would be non-adherent for a total sample size of 300 participants.
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However, the total sample size was increased to 350 participants in order to increase
statistical power for the proposed analyses. In addition, the proposal specified that after
reaching the target sample of participants adherent to CRC screening (n = 150),
individuals would be ineligible for this study if they were currently adherent to CRC
screening recommendations. However, given the high rates of CRC screening among
veterans accessing primary care services as well as lower rates of consent among those
who were non-adherent, the sample of 150 adherent veterans was achieved more rapidly
than the recruitment of those non-adherent to CRC screening guidelines. Due to
methodological concerns (i.e., confounding time of recruitment with adherence status), it
was decided that individuals from both groups (i.e., adherent and non-adherent) would
continue to be consented until the total sample size of 350 was reached.

Recruitment Procedures
The electronic medical records of male veterans aged 51-75 who were scheduled
for an upcoming primary care appointment to see their PCP or an RN at Roudebush
VAMC were reviewed for CRC screening adherence and history of a CRC diagnosis.
First, patient gender, age, and absence of a personal history of CRC were confirmed via
medical record in order to identify male veterans between the ages of 51 and 75 who may
be eligible for the study. Adherence to endoscopy [colonoscopy or sigmoidoscopy] or
stool blood test [FOBT or FIT] recommendations (e.g., stool blood test [FOBT or FIT] in
the past year or endoscopy [sigmoidoscopy in the past 5 years or colonoscopy in the past
10 years]) was noted based upon the date of the participant’s last FOBT, FIT,
sigmoidoscopy, or colonoscopy (if applicable) in the medical records. Individuals were
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considered CRC screening adherent if they had completed an FOBT or FIT in the past
year, a sigmoidoscopy in the past 5 years, or a colonoscopy in the past 10 years; CRC
screening adherence was coded as “yes” or “no.” While recognizing that there are
multiple screening modalities for those at average risk for the disease (Levin et al., 2008),
almost all U.S. veterans adherent to CRC screening recommendations receive FOBT,
colonoscopy, or sigmoidoscopy (Long et al., 2012). In addition, providers at Roudebush
VAMC have recently begun using FIT (Rao, personal communication, January 18, 2013).
Thus, only the performance of these screening behaviors (i.e., stool blood test [FOBT or
FIT] or endoscopy [sigmoidoscopy or colonoscopy]) were considered to be indicative of
CRC screening adherence during the review of patients’ medical records.
Individuals were consecutively approached in the primary care clinic waiting
room at the Roudebush VAMC before or after their PCP visit. The informed consent
process occurred in either a private area of the primary care clinic, away from other
patients in the primary care clinic waiting room, or in a clinic examination room. A
trained project coordinator or research assistant (RA) described the study, reviewed the
consent and authorization forms, answered questions, and invited veterans to participate.
During the informed consent process, the project coordinator or RA asked the participant
to verbalize his understanding of the study. If the veteran was unable to clearly describe
the study, he was considered ineligible due to likely cognitive impairment or language
difficulties. In addition, via a paper questionnaire, the veteran was asked if he: 1) had
been diagnosed with either colon or rectal cancer, Crohn’s disease, ulcerative colitis,
familial adenomatous polyposis, Lynch syndrome, or colon polyps in the past, and 2) had
a first-degree relative who had been diagnosed with CRC. Those with a familial history
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of CRC indicated whether a first-degree relative had been diagnosed with CRC prior to
the age of 60 and the number of first-degree relatives who had been diagnosed with CRC.
Veterans providing affirmative responses to any of the personal health questions and
those having two or more first-degree relatives with a history of CRC or a first-degree
relative with a diagnosis of CRC prior to age 60 were considered to be at high risk for
CRC and, thus, were ineligible for the study. This medical history information was
obtained via paper questionnaire so that the confidentiality of the patient’s medical
history was retained in the primary care clinic waiting room. The screening questionnaire
required approximately 3 minutes to complete. Interested, eligible veterans signed the
informed consent and HIPAA authorization form prior to study participation.

Data Collection Procedures
In order to minimize the impact of the study on the primary care clinic flow,
following informed consent and HIPAA authorization, the paper survey could be
completed before, during, and/or immediately after a clinic visit. The survey required
approximately 14 minutes to complete. The project coordinator or RA was available to
answer participants’ questions in the primary care clinic waiting room. After completing
the survey, the patient returned the survey to the project coordinator or RA. At that time,
the RA or project coordinator checked the questionnaire for omitted item responses. If
there were omissions, the research team member asked the participant whether he
intended to skip the item.
If the participant was unable to complete the survey while in clinic due to time
constraints, he was given an addressed, stamped envelope to complete the survey at home
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and return the survey to the project coordinator. If the survey was not returned within 14
days, the project coordinator or RA called the participant to remind him to complete and
return the survey. If the survey was not returned within 14 days of the reminder phone
call, the project coordinator or RA once again called the participant to remind him to
complete and return the survey to the research team. Upon completion, the participant
either hand-delivered (in the case of in-clinic completion) or mailed (in the case of athome completion) the survey to the project coordinator or RA, and the participant was
given a $10 Walmart gift card. In the case of individuals who completed their survey at
home, their gift card was sent via US mail after the survey had been returned to the
research team. The project coordinator collected the following information from the
medical records after completion of informed consent and HIPAA authorization forms: 1)
the date of first visit to the PCP, 2) the date of last colonoscopy, sigmoidoscopy, FOBT,
and/or FIT (if applicable), 3) medical diagnoses indicative of increased CRC risk (i.e.,
personal history of colon or rectal cancer, Crohn’s disease, ulcerative colitis, familial
adenomatous polyposis, Lynch syndrome, or colon polyps in the past, or two or more
first-degree relatives who have been diagnosed with CRC or a first-degree relative who
has been diagnosed with CRC prior to age 60), 4) zip code, and 5) PCP name.

Measures
Eligibility was assessed via medical record review and self-report. The self-report
screening survey included an assessment of personal health and family health diagnoses
which place one at higher risk for CRC to assess for eligibility (see Appendix A) (Centers
for Disease Control and Prevention, 2006; Rawl et al., under revision; Rawl et al., 2000;
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Rawl et al., 2005). Individuals identified as being at high risk of CRC were ineligible for
the study. Once enrolled, participants were asked to complete a paper survey (see
Appendix B). The survey included an assessment of demographic characteristics,
personal health characteristics, health experiences, trust in PCP, adherence to masculinity
norms, and cancer-related fear. The personal health characteristics and health experience
measures have been utilized in a large randomized controlled trial which investigated
CRC screening adherence following receipt of two CRC screening interventions
delivered in primary care (Christy et al., 2013; Rawl et al., under revision; Rawl et al.,
2012) as well as studies examining CRC screening adherence in those at increased risk
for the disease (Rawl et al., under review; Rawl et al., 2000; Rawl et al., 2005). Measures
of trust in PCP, adherence to masculinity norms, and cancer-related fear have been wellvalidated (Champion et al., 2004; Dugan, Trachtenberg, & Hall, 2005; Parent & Moradi,
2009; Parent & Moradi, 2011; Parent, Moradi, Rummell, & Tokar, 2011).
Demographic Characteristics. Seven items were used to assess demographic
information, including age, race, marital status, employment status, income, health
insurance status, and education (Centers for Disease Control and Prevention, 2011;
Mosher et al., 2012). With the individual’s permission, the following information was
collected from his medical record: length of patient-provider relationship (first visit with
current PCP subtracted from date of consent), CRC screening adherence, CRC screening
test modality completed (if applicable), and CRC risk factors (personal history of colon
or rectal cancer, Crohn’s disease, ulcerative colitis, familial adenomatous polyposis,
Lynch syndrome, or colon polyps in the past or having a close family relative who had
been diagnosed with CRC prior to age 60 or two or more close family relatives who had
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been diagnosed with CRC). Although the participant may have been seen by an RN
during the current visit, the length of his relationship with his PCP was obtained rather
than the length of his relationship with the RN because the PCP was likely to be the
provider referring the participant for CRC screening. Adherence to colonoscopy,
sigmoidoscopy, or FOBT/FIT recommendations (i.e., colonoscopy in the past 10 years,
sigmoidoscopy in the past 5 years, or FOBT or FIT in the past year) was also collected
based upon the date of the participant’s last colonoscopy, sigmoidoscopy and/or stool
blood test [FOBT or FIT] (if applicable).
Health Information and Behaviors. Sixteen items assessed patients’ personal
cancer history, whether they had a distant relative, friend, or co-worker who had been
diagnosed with CRC, CRC screening behaviors, and prior recommendations for CRC
screening from a physician, family member, or friend. The majority of these questions
were used in an NCI-funded randomized controlled trial examining CRC screening
adherence among primary care patients (Christy et al., 2013; Rawl et al., under revision;
Rawl et al., 2012) and utilize “yes” or “no” responses. The CRC screening behavior
items were modified from measures developed by Rawl and colleagues (2000, 2005,
2012, under revision, under review). In the original studies, these items were delivered
via telephone; in the current study, the items regarding the time of the veteran’s last CRC
screening test were modified so that participants could respond to these open-ended
questions via paper survey. Although CRC screening adherence was gathered from the
participants’ medical record, some participants received CRC screening outside of the
VAMC system and medical record data confirming that procedure were not always
available. Thus, participants were asked whether they underwent FOBT or FIT in the
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past year, flexible sigmoidoscopy in the past 5 years, or colonoscopy in the past 10 years
and the location of these tests, if applicable. In the case of discrepancy between the
medical record and self-report, the medical record data were used to determine screening
status. Often, the medical record clearly identified CRC screening adherence as
evidenced by either receipt of the screening test at the VAMC or by scanned medical
records from an outside facility. However, if patients had reported adherence to CRC
screening at an outside facility to their PCP (i.e., noted by the PCP in the medical record),
but this was not supported by outside records which had been entered into the medical
record and they reported non-adherence to CRC screening on the study survey, patients
were coded as non-adherent. Given the research questions posed, individuals who were
adherent to both stool blood test and endoscopy at the time of consent were coded as
adherent to endoscopy.
Trust in PCP. Five items assessed the patient’s trust in his PCP (Dugan et al.,
2005). In the original measure development study, participants responded to items over
the phone such as “sometimes Dr._ [INSERT NAME OF DR.]__ cares more about what
is convenient for (him/her) than about your medical needs,” which were individualized
with the participants’ doctor’s name (Dugan et al., 2005). Test-retest reliability of the
measure over two months was 0.71 and Cronbach’s alpha was 0.87 (Dugan et al., 2005).
In the current study, participants were asked to think about their PCP while responding to
items such as “sometimes your doctor cares more about what is convenient for him or her
than about your medical needs.” Responses were measured on a 5-point, Likert-type
scale with responses ranging from 1 (strongly disagree) to 5 (strongly agree) (Dugan et
al., 2005). In the current study, the internal consistency reliability of this scale was .870.
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Conformity to Masculine Norms Inventory-46. The Conformity to Masculine
Norms Inventory-46 (CMNI-46) (Parent & Moradi, 2009) is a 46-item, shortened version
of the original 94-item Conformity to Masculine Norms Inventory (Mahalik et al., 2003).
Forty-six items assessed the following masculinity norms: Risk-taking, Winning,
Violence, Emotional Control, Self-reliance, Power Over Women, Playboy, Primacy of
Work, and Heterosexual Self-Presentation (Parent & Moradi, 2009). Internal consistency
reliability of the 46-item measure was adequate in the original measure development
study (α = 0.82) (Parent & Moradi, 2011). In addition, correlations between the
subscales of the original Conformity to Masculine Norms Inventory and those of the 46item version ranged from 0.89 to 0.98 (Mahalik et al., 2003; Parent & Moradi, 2009).
Responses were measured using a four-point Likert-type scale ranging from 0 (strongly
disagree) to 3 (strongly agree).
Three subscales of the measure (i.e., heterosexual self-presentation, risk-taking,
and self-reliance) were examined in this study. The following items were reverse-scored:
5, 6, 10, 17, and 38 (Parent & Moradi, 2009; Parent & Moradi, 2011). Items 5, 14, 17,
24, 37, and 46 were summed and the average was taken to determine the heterosexual
self-presentation subscale score (Parent & Moradi, 2009; Parent & Moradi, 2011). In the
current study, internal consistency reliability of this subscale was .852. For the risktaking subscale score, items 6, 8, 16, 28, and 35 were summed and the average was
determined (Parent & Moradi, 2009; Parent & Moradi, 2011). Internal consistency
reliability of this subscale was .698 in the present study. Finally, items 3, 10, 26, 38, and
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43 were summed and averaged to calculate the self-reliance subscale score (Parent &
Moradi, 2009; Parent & Moradi, 2011). In the current study, internal consistency
reliability of this subscale was .746.
Cancer-related Fear. Cancer-related fear was measured using eight items modified
from the Breast Cancer Fear Scale developed by Champion and colleagues (2004). In the
original study, eight items were retained (e.g., “when I think about breast cancer, I feel
anxious”); in the current study, the specifier of “breast” cancer was deleted so that the
eight items would reflect general cancer fear (e.g., “when I think about cancer, I feel
anxious”) (Champion et al., 2004). Reliability of the Breast Cancer Fear Scale has been
established; Cronbach’s alpha was shown to be α = 0.91 and two to three month testretest reliability was demonstrated to be 0.70 (Champion et al., 2004). Responses were
measured using a five-point, Likert-type scale, ranging from 1 (strongly disagree) to 5
(strongly agree) (Champion et al., 2004). The mean of the summed score was used in
analyses. Internal consistency reliability of this scale was .922 in the present study.

Statistical Analyses
Data Cleaning and Reduction. All data were analyzed using SPSS (Version 22,
Copyright © 2013 IBM SPSS Statistics, Chicago, IL, USA). First, the amount of missing
data was determined (Schafer & Graham, 2002). Next, it was determined whether data
were missing at random or if there was a pattern in nonresponse (Schafer & Graham,
2002). Using Little’s MCAR test, it was determined that data were not missing
completely at random. A variety of methods for handling missing data were considered
including casewise deletion, listwise deletion, maximum likelihood (ML), and single and
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multiple imputation (MI). Ultimately, series mean imputation was chosen because in the
case of all but the income variable, less than 5% of any data were missing. The
dissertation proposal stated that single imputation would be used in the case of variables
missing less than 5%, multiple imputation would be used in the case of variables missing
more than 5%, and NORM software would be utilized to impute five data sets. However,
it was found that only one variable, income, had missing data greater than this amount
(6.7% missingness) and that the NORM software was out-of-date. Given the low amount
of missing data, series mean imputation was instead utilized, and values were randomly
assigned (Rand, personal communication, September 22, 2014). All study scale scores
and the length of the patient-provider relationship were calculated prior to conducting the
primary analyses. The length of the patient-provider relationship was calculated by
subtracting the date of the participant’s first visit to his PCP (as reported in the electronic
medical record) from the date of consent. In addition, physician recommendation for
CRC screening was calculated such that individuals responding “yes” to any of the three
questionnaire items assessing whether they had received a recommendation for stool
blood test, sigmoidoscopy, or colonoscopy from their doctor were coded as having
received a physician recommendation. Individuals at increased risk for CRC and those
who consented, but failed to complete more than 60% of the study questionnaire, were
excluded from analyses.
Preliminary analyses (i.e., descriptive statistics, scatterplots, histographs, residual
score analysis) were conducted to examine the data for normality, linearity, kurtosis,
homoscedasticity, and outliers. Outliers were examined as potential data entry errors.
Descriptive statistics were computed to characterize the participants’ demographic
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characteristics, health experiences, trust in PCP, cancer fear, masculinity subscale scores,
and CRC screening adherence. Correlations between study variables were also
computed. Ultimately, data from 327 individuals were analyzed.
Analyses for Aim #1. Analyses for Aim #1 examined the extent to which three
aspects of masculinity (i.e., heterosexual self-presentation, risk-taking, and self-reliance)
were associated with CRC screening adherence (i.e., stool blood test [FOBT or FIT] in
the past year or endoscopy [sigmoidoscopy in the past 5 years or colonoscopy in the past
10 years]) while controlling for age, race, and education level. It was hypothesized that
three aspects of masculinity (i.e., heterosexual self-presentation, risk-taking, and selfreliance) would be inversely associated with CRC screening adherence (i.e., stool blood
test [FOBT or FIT] in the past year or endoscopy [sigmoidoscopy in the past 5 years or
colonoscopy in the past 10 years]) (see Aim #1, Hypothesis #1.1). To test this
hypothesis, three separate logistic regression analyses were conducted to examine the
relationship between the masculinity variables (i.e., heterosexual self-presentation, risktaking, and self-reliance) and CRC screening adherence (coded “yes” or “no”) while
controlling for age, race, and education level.
Analyses for Aims #2 and #3. Using the Hayes (2012, 2013) PROCESS macro,
analyses were conducted to examine whether: 1) the relationship between risk-taking and
CRC screening adherence was partially mediated by cancer fear (Aim #2, Hypothesis
#2.1) while controlling for age, race, and education level; 2) the relationship between
self-reliance and CRC screening adherence was partially mediated by trust in PCP (Aim
#2, Hypothesis #2.2) while controlling for age, race, and education level; 3) age
moderated the strength of the relationship between cancer fear and CRC screening
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adherence such that the relationship between cancer fear and CRC screening was weaker
with increasing age (Aim #3, Hypothesis #3.1) while controlling for race and education
level; 4) race moderated the strength of the relationship between trust in PCP and CRC
screening adherence such that the relationship between trust in PCP and CRC screening
was stronger among African-Americans compared to Whites (Aim #3, Hypothesis #3.2)
while controlling for age and education level; and 5) length of patient-provider
relationship moderated the strength of the relationship between trust in PCP and CRC
screening adherence such that the relationship between trust in PCP and CRC screening
was stronger with increasing length of patient-provider relationship (Aim #3, Hypothesis
#3.3) while controlling for age, race, and education level.
Both Preacher and Hayes’s method of moderated mediation and structural
equation modeling were considered for analyses (Hayes, 2009). After careful
consideration, it was decided that Preacher and Hayes’s method of moderated mediation
would be used in this study (Hayes, 2009). With moderated mediation, a researcher is
able to examine whether a variable (X) affects an outcome (Y) indirectly through a
mediator, and if that indirect effect is stronger among certain groups of participants (a
moderator) (Hayes, 2009, 2013). Use of the Hayes (2012, 2013) PROCESS macro
allowed for a direct test of the proposed pathways and relationships among variables. If
structural equation modeling analyses had been used, it would have required a multiple
group comparison of models without allowing for a direct test of the proposed pathways
and relationships (Hayes, 2009, 2013).
The PROCESS macro combines Hayes’s prior macros (i.e., MODMED,
MODPROBE, SOBEL, INDIRECT, and MEDTHREE/MED3C) and allows for more
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complex analyses than did previously available macros (Hayes, 2012, 2013). Using
bootstrapping, the PROCESS macro examines indirect effects of moderated mediation
through logistic regression or ordinary least squares regression analyses (Hayes, 2012,
2013). Bootstrapping allowed for the examination of the indirect effects of masculinity
beliefs on CRC screening adherence through health beliefs such as cancer fear and trust
in PCP through resampling from the data set five thousand times (Preacher & Hayes,
2004; Preacher & Hayes, 2008; Shrout & Bolger, 2002). Advantages of the
bootstrapping method include the lack of assumption of normality and enhanced power to
detect indirect effects relative to older statistical methods (Preacher & Hayes, 2004;
Preacher & Hayes, 2008; Shrout & Bolger, 2002). The bootstrapping method was used
to estimate a 95% confidence interval; if the confidence interval did not include zero, the
indirect effect was considered statistically significant (Preacher & Hayes, 2004; Preacher
& Hayes, 2008; Shrout & Bolger, 2002).
Demographic covariates were included in all models. Specifically, because
higher education has been associated with performance of CRC screening in prior
research (Beydoun & Beydoun, 2008; Cokkinides, Chao, Smith, Vernon, & Thun, 2003;
Halbert et al., 2011), education (i.e., HS diploma, GED, or less education vs. some
college or more education) was included as a covariate in all models. In addition, older
age has been associated with receipt of CRC screening (Beydoun & Beydoun, 2008;
Cokkinides et al., 2003; Tessaro et al., 2006). Thus, age was a covariate in all models,
with the exception of Aim #3, Hypothesis #3.1, which included age as a moderator.
Furthermore, because White race has been associated with a higher likelihood of CRC
screening in prior research (Beydoun & Beydoun, 2008), race (i.e., White vs. minority
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race) was a covariate in all models with the exception of Aim #3, Hypothesis #3.2, which
included race (i.e., White vs. Black or African-American race) as a moderator.
Because the PROCESS macro uses bias-corrected bootstrapping to correct for
data with a non-normal distribution (Hayes, 2012, 2013), the work of Fritz and
MacKinnon (2009) was consulted in order to determine the appropriate sample size to
obtain 80% power. It would have been ideal to have an estimate of effect size in order to
determine the necessary sample size for this study (Fritz & MacKinnon, 2007); however,
because no prior study has examined the relationship between masculinity and CRC
screening adherence, the effect size for the study was unknown. According to Fritz and
MacKinnon (2009), for a study involving bias-corrected bootstrapping, a sample size
between 34 (for large α and β effect sizes) and 462 (for small α and β effect sizes) is
required. It was hypothesized that the effect sizes for α and β in the proposed study
would likely be small or medium. Thus, with 350 participants, a moderate effect size
(Cohen’s d = 0.39) or 13% of the variance in the model may have been able to be
detected with 80% power depending upon the effect sizes of the α and β paths (Fritz &
MacKinnon, 2007).
Analyses for Aim #4. Aim #4, Hypothesis #4.1 stated that aspects of masculinity
(i.e., heterosexual self-presentation, risk-taking, and self-reliance) would predict CRC
screening adherence above and beyond the predictive value of race, age, education,
physician recommending CRC screening, and family/friend recommending CRC
screening. To test this hypothesis, logistic regression analyses were conducted with race,
education, age, physician recommendation for CRC screening, and family or friend
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recommendation for CRC screening entered on the first step of the equation and the three
masculinity variables entered on the second step.
Analyses for Aim #5. The fifth aim was to examine associations between three
aspects of masculinity (i.e., heterosexual self-presentation, risk-taking, and self-reliance)
and CRC screening status (i.e., non-adherence, adherence with stool blood test [FOBT or
FIT in the past year], or adherence with endoscopy [sigmoidoscopy in the past 5 years or
colonoscopy in the past 10 years]) in male VA primary care patients aged 51-75 while
controlling for age, race, and education level. To address this aim, a multinomial logistic
regression analysis was used to examine the extent to which three aspects of masculinity
predicted stool blood test screening (relative to non-adherence) and endoscopic screening
(relative to non-adherence) while controlling for age, race, and education level.
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RESULTS

Study Flow
A total of 561 male veterans with a scheduled PCP visit were approached
regarding the study. One hundred and fifty-six veterans declined to participate either
prior to (n = 151) or following eligibility screening (n = 5). Reasons for refusal include
lack of interest, concern that participation would be too much work, health reasons, prior
negative experiences with CRC screening, privacy concerns, enrollment or considering
enrollment in another CRC study, and lack of time, among others (see Figure 1). Of note,
five of the individuals who declined participation also mentioned being unable to
complete paperwork or read. However, these 5 responses were considered refusals
because the veterans were not adequately screened for eligibility (i.e., the ability to read
and write). An additional 55 individuals were found to be ineligible during the screening
or consent process. Reasons for ineligibility were based upon responses to the screening
questionnaire (n = 24) and information gathered during the consent process (n = 31; e.g.,
demonstration of cognitive impairment, verbal report of ineligibility criteria). Interested
and eligible veterans (N = 350) consented to participate in the study. Study flow and
reasons for refusal and ineligibility are found in Figure 1.
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Participant Characteristics
Of the 350 consenting individuals, 233 (67%) were adherent to current CRC
screening guidelines and 117 were non-adherent. Twenty-three individuals either did not
return their study questionnaires or returned questionnaires which had extensive missing
data; thus, data from 327 participants were included in the current analyses. Of these,
213 individuals (65%) were adherent to CRC screening guidelines at the time of consent.
Of the adherent participants, 196 individuals were adherent through the following tests:
1) colonoscopy alone, 2) both colonoscopy and sigmoidoscopy, or 3) both colonoscopy
and stool blood testing. The other 17 adherent participants were adherent to stool blood
testing alone. The remaining 114 individuals were non-adherent to CRC screening
guidelines at the time of consent.
Sample characteristics are displayed in Table 2. The average age of study
participants was 62 years (SD = 5.8). The majority of participants self-identified as
White or Caucasian (73%), and 21% identified as Black or African American. Fifty-five
percent were married and 64% had completed at least one semester of college. Most
participants were unemployed or retired (69%), and more than half lacked health
insurance other than VA benefits (59%) and reported a household income of less than
$31,000 (59%). According to medical records, about half of participants had a female
PCP (50.2%), and the average length of time that participants had seen their PCP was 48
months (SD = 46.57). Of note, 8.6% of participants did not have an identified PCP
recorded in the medical record. The majority of participants (91%) reported that they had
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received a recommendation from their physician to receive CRC screening, and 55% of
participants reported that their family members or friends had recommended that they
complete CRC screening.

Correlations Between Study Variables
Intercorrelations between study variables are displayed in Table 3. Briefly,
correlational analyses showed that older age was associated with increased likelihood of
CRC screening adherence (p < 0.001). Furthermore, White race was correlated with
older age (p = 0.023), increased risk-taking (p = 0.008), and lower levels of heterosexual
self-presentation (p = 0.020). Greater education was correlated with lower levels of
heterosexual self-presentation and cancer fear (p = 0.002 and p = 0.044, respectively) as
well as increased risk-taking and CRC screening adherence (p = 0.014 and p = 0.022,
respectively). In addition, risk-taking was negatively correlated with heterosexual selfpresentation (p = 0.015) and positively correlated with self-reliance (p = 0.019). Selfreliance also was positively associated with cancer fear (p = 0.015) and negatively
associated with trust in one’s PCP (p = 0.004). Having received a family member or
friend recommendation for CRC screening was correlated with reduced trust in PCP (p =
0.005, greater cancer fear (p = 0.019), and receipt of a PCP recommendation for CRC
screening (p = 0.031). Receiving a recommendation for CRC screening from a PCP or
family member or friend was associated with increased likelihood of CRC screening
adherence (p < .001 and p = 0.034, respectively). No additional significant relationships
were found between study variables.
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Aim 1 Results
Examine the extent to which three aspects of masculinity (i.e., heterosexual selfpresentation, risk-taking, and self-reliance) are associated with CRC screening
adherence (i.e., stool blood test [FOBT or FIT] in the past year or endoscopy [i.e.,
sigmoidoscopy in the past 5 years or colonoscopy in the past 10 years]) in male VA
primary care patients aged 51-75 while controlling for age, race, and education level..
Hypothesis 1.1 posited that three aspects of masculinity (i.e., heterosexual selfpresentation, risk-taking, and self-reliance) would be inversely associated with CRC
screening adherence (i.e., stool blood test [FOBT or FIT] in the past year or endoscopy
[sigmoidoscopy in the past 5 years or colonoscopy in the past 10 years]) while controlling
for age, race, and education level. To test this hypothesis, each of the masculinity
variables was examined as a predictor of CRC screening adherence in separate logistic
regression analyses. As shown in Figures 2-4, none of the masculinity variables were
significant predictors of screening status while controlling for age, education level, and
race. In each of the three models, increasing age and lower levels of education were
predictive of receiving CRC screening according to guidelines, whereas race did not
predict this outcome (see Table 4).

Aim 2 Results
Examine potential mediators of the relationship between aspects of masculinity (i.e., risktaking and self-reliance) and CRC screening adherence (i.e., stool blood test [FOBT or

43
FIT] in the past year or endoscopy [sigmoidoscopy in the past 5 years or colonoscopy in
the past 10 years]) in male VA primary care patients aged 51-75 while controlling for
age, race, and education level.
Hypothesis 2.1 postulated that cancer fear would partially mediate the relationship
between risk-taking and CRC screening adherence (i.e., stool blood test [FOBT or FIT] in
the past year or endoscopy [sigmoidoscopy in the past 5 years or colonoscopy in the past
10 years]) while controlling for age, race, and education level. To test this hypothesis,
the indirect effect of risk-taking on CRC screening adherence through cancer fear was
calculated using the bootstrapping method in the PROCESS macro (indirect effect =
0.0053, SE = 0.0238, p = 0.7892, 95% CI = -0.0202 to 0.0904; see Tables 5 and 6). As
shown in Figure 5, cancer fear did not mediate the relationship between risk-taking and
CRC screening adherence. There were no significant paths in the model.
Regarding Hypothesis 2.2, it was expected that trust in PCP would partially
mediate the relationship between self-reliance and CRC screening adherence (i.e., stool
blood test [FOBT or FIT] in the past year or endoscopy [sigmoidoscopy in the past 5
years or colonoscopy in the past 10 years]) while controlling for age, race, and education
level. To test this hypothesis, the indirect effect of self-reliance on CRC screening
adherence through trust in PCP was calculated using the bootstrapping method in the
PROCESS macro (indirect effect = 0.0091, SE = 0.0480, p = 0.8388, 95% CI = -0.0791
to 0.1205; see Tables 5 and 7). As shown in Figure 6, trust in PCP did not mediate the
relationship between self-reliance and CRC screening adherence. The only significant
path in this model was a negative relationship between self-reliance and trust in PCP (B =
-0.3104, p = 0.005, 95% CI = -0.5241 to -0.0967).
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Aim 3 Results
Examine potential moderators of relationships specified in the models proposed in Aim
#2 while controlling for demographic covariates.
Hypothesis 3.1 posited that age would moderate the strength of the relationship
between cancer fear and CRC screening adherence such that the relationship would be
weaker with increasing age while controlling for race and education level. To test this
hypothesis, a conditional process model was examined using the PROCESS macro. As
shown in Figure 7, results indicated that age did not moderate the relationship between
cancer fear and CRC screening adherence (index of moderation mediation = 0.0024, SE =
0.0061, 95% CI = -0.0050 to 0.0232; see Tables 8 and 9). There were no significant
paths in the model.
Regarding Hypothesis 3.2, it was suggested that race would moderate the strength
of the relationship between trust in PCP and CRC screening adherence such that the
relationship would be stronger among African Americans compared to Whites while
controlling for age and education level. The PROCESS macro was again used to test this
conditional process model. As shown in Figure 8, race did not moderate the relationship
between trust in PCP and CRC screening adherence (index of moderation mediation = 0.0241, SE = 0.1268, 95% CI = -0.3176 to 0.2058; see Tables 8 and 10). The only
significant path in the model was a negative relationship between self-reliance and trust
in PCP (B = -0.3143, SE = 0.1078, p = 0.0038, 95% CI = -0.5264 to -0.1023).
Hypothesis 3.3 posited that length of patient-provider relationship would
moderate the strength of the relationship between trust in PCP and CRC screening
adherence such that the relationship would be stronger with increasing length of patient-
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provider relationship while controlling for age, race, and education level. As shown in
Figure 9, results of analyses using the PROCESS macro indicated that length of patientprovider relationship did not moderate the relationship between trust in PCP and CRC
screening adherence (index of moderation mediation = -0.0005, SE = 0.0013, 95% CI = 0.0036 to 0.0018; see Tables 8 and 11). The only significant path in the model was a
negative relationship between self-reliance and trust in PCP (B = -0.3104, SE = 0.1086, p
= 0.0046, 95% CI = -0.5241 to -0.0967).

Aim 4 Results
Examine the extent to which three aspects of masculinity (i.e., heterosexual selfpresentation, risk-taking, and self-reliance) are associated with CRC screening behavior,
controlling for the effects of variables recognized as significant predictors of CRC
screening in prior research (i.e., White race, older age, higher education level, physician
recommending CRC screening, family and friends recommending CRC screening).
Hypothesis 4.1 suggested that three aspects of masculinity (i.e., heterosexual selfpresentation, risk-taking, and self-reliance) would predict CRC screening adherence
above and beyond the predictive value of race, age, education, physician recommending
CRC screening, and family/friend recommending CRC screening. To test this
hypothesis, a hierarchical logistic regression analysis was conducted with four variables
entered on the first step (i.e., race, age, education, physician recommending CRC
screening, and family/friend recommending CRC screening) and the three masculinity
variables entered on the second step. Results did not support Hypothesis 4.1 (see Table
12). Furthermore, physician recommendation for CRC screening and age were the only

46
significant predictors of CRC screening adherence in the model. Specifically, lack of
physician recommendation for CRC screening (B = -2.677, p < 0.001, 95% CI = 0.022 to
0.212) and increasing age (B = 0.084, p < 0.001, 95% CI = 0.382 to 1.096) were
associated with CRC screening adherence.

Aim 5 Results
Examine associations between three aspects of masculinity (i.e., heterosexual selfpresentation, risk-taking, and self-reliance) and CRC screening status (i.e., nonadherence, adherence with stool blood test [FOBT or FIT in the past year], or adherence
with endoscopy [sigmoidoscopy in the past 5 years or colonoscopy in the past 10 years])
in male VA primary care patients aged 51-75 while controlling for age, race, and
education level.
A multinomial logistic regression analysis was conducted to address this
exploratory aim. As shown in Table 13, none of the masculinity variables (i.e.,
heterosexual self-presentation, risk-taking, and self-reliance) were predictive of CRC
screening adherence. When examining adherence to endoscopy, older age (B = 0.082, p
< 0.001, 95% CI = 1.040 to 1.134) and higher levels of education were significant
predictors of this outcome (B = 0.565, p = 0.028, 95% CI = 1.064 to 2.908), whereas,
when examining adherence to a stool blood test, none of the examined variables were
predictive of this outcome. Of note, SPSS produced an error message when completing
this analysis which was likely related to the small number of participants adherent to
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CRC screening guidelines with stool blood test only (n = 17) (Rand, personal
communication, September 19, 2014). Thus, caution when interpreting the results of this
analysis is warranted.
Given the small number of participants adherent to CRC screening guidelines
with stool blood test only, an additional logistic regression analysis was conducted after
omitting data from these individuals. This analysis examined the extent to which three
aspects of masculinity (i.e., heterosexual self-presentation, risk-taking, and self-reliance)
predicted adherence to endoscopy while controlling for age, race, and education level. In
this model, none of the masculinity variables were predictive of endoscopy status.
Instead, this status was only associated with age (B = 0.086, p < 0.001, 95% CI = 1.0421.138) and education level (B = -0.580, p = 0.024, 95% CI = 0.339-0.926) (see Table 14).
Specifically, increasing age and lower levels of education were associated with
completion of CRC screening with endoscopic tests.
To summarize the relations of covariates to CRC screening adherence across
analyses, age and race showed consistent relationships with this outcome, whereas
education did not. Specifically, older age was associated with increased likelihood of
CRC screening adherence and race was uncorrelated with this outcome across all
analyses. Higher levels of education were only related to increased CRC screening
adherence in bivariate correlational analyses and the multinomial logistic regression
analysis which created the error message. Conversely, in the majority of regression
analyses, lower levels of education were related to increased likelihood of CRC screening
adherence.
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DISCUSSION

Summary of Study Results
Colorectal cancer is the third most common cause of cancer deaths and yet, CRC
screening rates are suboptimal among men in the United States (American Cancer
Society, 2014a; American Cancer Society, 2014b). With improved understanding of
barriers to CRC screening adherence, interventions can be designed to address these
barriers, increase CRC screening rates, and decrease mortality from CRC. In the present
study, masculinity beliefs were examined as potential barriers to men’s CRC screening
adherence because qualitative studies have provided suggestive evidence of this
relationship (Bass et al., 2011; Beeker et al., 2000; Getrich et al., 2012; Goldman et al.,
2009; Harvey & Alston, 2011; Holt et al., 2009; Jilcott Pitts et al., 2013; Jones, Devers, et
al., 2010; Rivera-Ramos & Buki, 2011; Thompson et al., 2011; Wackerbarth et al., 2005;
Winterich et al., 2009).
The primary aim of this study was to test the hypothesis that the masculinity
variables of heterosexual self-presentation, self-reliance, and risk-taking would be
inversely associated with CRC screening adherence. These three masculinity variables
were chosen because prior qualitative research and masculinity theory suggest the
following: 1) masculine men should present themselves as heterosexual and, by
extension, distain cancer screening involving the rectum (e.g., colonoscopy) which could
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affect their perceptions of their sexuality (Brannon, 1976; Getrich et al., 2012; Harvey &
Alston, 2011; Holt et al., 2009; Jones, Devers, et al., 2010; Thompson et al., 2011;
Winterich et al., 2011); 2) men with higher levels of risk-taking beliefs may not perceive
disease such as CRC to be a threat to their well-being and, thus, may not engage in
preventive behaviors such as CRC screening (Bem, 1974; Courtenay, 2000a, 2000b,
2011; Millar & Houska, 2007; Nicholas, 2000); and 3) men who endorse self-reliance
ideals may not consistently receive health care, which limits their opportunity to receive a
recommendation for CRC screening (Boman & Walker, 2010; Hammond, Matthews, &
Corbie-Smith, 2010; Iwamoto et al., 2011; Locke & Mahalik, 2005; Mahalik et al., 2006;
Mahalik et al., 2003; Pachankis et al., 2011; Pleck et al., 1993; Wade, 2009).
Contrary to the primary study hypothesis, none of these masculinity variables
were significantly associated with CRC screening adherence in bivariate correlational or
logistic regression analyses controlling for established predictors of the outcome.
Specifically, these three aspects of masculinity failed to predict CRC screening adherence
above and beyond the predictive value of race, age, education, physician
recommendation, and family/friend recommendation. However, results suggested that
lack of physician recommendation for CRC screening and increasing age were associated
with a higher likelihood of CRC screening adherence.
A multinomial logistic regression analysis also was used to examine the extent to
which the three aspects of masculinity predicted stool blood test screening (relative to
non-adherence) and endoscopic screening (relative to non-adherence) while controlling
for age, race, and education level. However, only 17 individuals in the sample were
adherent to CRC with stool blood test alone, and the statistical software produced an
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error message. Due to the small number of participants adherent to CRC screening
guidelines with stool blood test alone, a final logistic regression analysis was conducted
after omitting data from these individuals. This analysis examined the extent to which
the three masculinity variables predicted endoscopic screening relative to non-adherence.
Results showed that none of the masculinity variables predicted endoscopic screening.
In addition, analyses were conducted to test mediational and moderated
mediational models of the relationships between two aspects of masculinity (i.e., risktaking and self-reliance) and CRC screening adherence. The following models were
hypothesized: 1) cancer fear would partially mediate the relationship between risk-taking
and CRC screening adherence; 2) trust in PCP would partially mediate the relationship
between self-reliance and CRC screening adherence; 3) age would moderate the strength
of the relationship between cancer fear and CRC screening adherence; 4) race would
moderate the strength of the relationship between trust in PCP and CRC screening
adherence; and 5) length of patient-provider relationship would moderate the strength of
the relationship between trust in PCP and CRC screening adherence. Mediation and
moderated mediation analyses did not support any of the five hypothesized models;
however, a significant negative relationship was found between self-reliance and trust in
PCP.
Regarding study covariates, increasing age was associated with a higher
likelihood of CRC screening adherence, and race was unrelated to this outcome across all
analyses. In addition, level of education (i.e., whether one had a history of college
attendance) was inconsistently associated with adherence to CRC screening. In multiple
regression analyses, lower levels of education was a significant predictor of CRC
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screening adherence. However, in one of the regression analyses (i.e., the multinomial
logistic regression analysis which produced an error message), mediation and moderated
mediation analyses, and the bivariate correlational analysis, higher levels of education
were associated with CRC screening adherence. In yet another regression analysis, level
of education was not a significant predictor of CRC screening adherence. Potential
explanations for study findings are provided below.

Fit with Existing Literature
Results of qualitative studies suggest that masculinity beliefs may be related to
men’s willingness to undergo endoscopic CRC screening (Bass et al., 2011; Beeker et al.,
2000; Getrich et al., 2012; Goldman et al., 2009; Harvey & Alston, 2011; Holt et al.,
2009; Jilcott Pitts et al., 2013; Jones, Devers, et al., 2010; Rivera-Ramos & Buki, 2011;
Thompson et al., 2011; Wackerbarth et al., 2005; Winterich et al., 2009). To the author’s
knowledge, prior quantitative studies have not examined associations between
masculinity beliefs and CRC screening. The present findings suggest that three
masculinity beliefs (i.e., heterosexual self-presentation, risk-taking, and self-reliance)
may not in fact be associated with CRC screening adherence. However, previous
research suggests that two of these facets of masculinity (i.e., heterosexual selfpresentation and self-reliance) are related to other health behaviors in men (Hammond,
Matthews, Mohottige et al., 2010; Mahalik, Levi-Minzi, & Walker, 2007; Levant,
Wimer, & Williams, 2011; Parent, Torrey, & Michaels, 2012). For example,
heterosexual self-presentation was negatively associated with HIV testing among men
who have sex with men (Parent, Torrey, & Michaels, 2012). In addition, in a study of
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adult men aged 18-78, the masculinity subscales of self-reliance, violence, and playboy
predicted health risk behaviors (e.g., unhealthy lifestyle choices and substance use),
whereas other masculinity subscales (e.g., risk-taking, heterosexual self-presentation) did
not predict these behaviors (Mahalik, Levi-Minzi, & Walker, 2007; Levant, Wimer, &
Williams, 2011). Another study of self-reliance in men produced counterintuitive
findings; greater self-reliance was associated with more prompt receipt of cholesterol
screening (Hammond, Matthews, Mohottige et al., 2010). In addition, self-reliance was
unrelated to the receipt of blood pressure screening or a routine medical check-up
(Hammond, Matthews, Mohottige et al., 2010). Thus, given the limited research to date,
a clear pattern of associations between the masculinity ideals of self-reliance and
heterosexual self-presentation and health behaviors has not emerged.
Although theory suggests that adherence to the masculinity ideal of risk-taking
might lead to decreased worry about health and less engagement in healthy behaviors
(Brannon, 1976; Courtenay, 2011; Nicholas, 2000; Parent & Moradi, 2009; Walker,
Tokar, & Fischer, 2000), risk-taking has not been found to be associated with preventive
health behaviors in men (Hammond, Matthews, Mohottige et al., 2010; Mahalik, LeviMinzi, & Walker, 2007; Levant, Wimer, & Williams, 2011; Parent, Torrey, & Michaels,
2012). Thus, findings of the current study are consistent with prior empirical literature,
but do not support masculinity theory (Brannon, 1976; Courtenay, 2000a, 2000b, 2011).
It is important to note that the risk-taking ideal has been measured with items such as “I
take risks” and “I frequently put myself in risky situations” (Parent & Moradi, 2009).
Thus, a willingness to take risks rather than beliefs about vulunerability to health risks is
the construct under examination in the current study and prior research. Developing

53
masculinity measures which assess perceived risk and vulnerability to disease or poor
health would allow further testing of masculinity theory. Further research is also needed
to assess whether the masculinity ideal of risk-taking is more strongly associated with
risky health behaviors than a lack of preventive health behaviors among men. Indeed, in
one study of men, adherence to the risk-taking ideal was associated with drinking alcohol
to intoxication (Iwamoto et al., 2011).
It is also possible that masculinity ideals not considered in the current study, such
as the primacy of work and pursuit of status, may be associated with CRC screening
behaviors. To date, studies have found variable associations between a range of
masculinity ideals and health behaviors in men. For example, in one study, the
masculinity ideals of primacy of work and dominance were positively associated with
preventive health behaviors (i.e., testicular self-exam, skin cancer self-exam, and an
annual physical exam), whereas the pursuit of status was negatively associated with these
behaviors (Levant, Wimer, and Williams, 2011). However, other masculinity ideals (e.g.,
self-reliance, disdain for homosexuality, violence) were not associated with these health
behaviors (Levant, Wimer, and Williams, 2011). The authors also found variable
associations between aspects of masculinity and health risk behaviors, which led them to
conclude the following:
the relationship between health behavior and masculine gender socialization
varies according to specific dimension of health behavior and the specific
masculine gender socialization construct. It seems from these data and prior
research that some facets of masculinity are associated with health protective
factors, whereas others are associated with health risk factors (Levant, Wimer,
and Williams, 2011, pg. 26).
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Thus, the relationship between aspects of masculinity and health behaviors in men is
quite complex such that further theory development and multi-faceted assessment of
constructs are needed. Unfortunately, many studies use a total masculinity score rather
than subscale scores, which limits theoretical progress and comparisons between the
current study and prior studies (Boman & Walker, 2010; Mahalik & Burns, 2011;
Mahalik, Burns, & Syzdek, 2007; Springer & Mouzon, 2011).
Potential mediators of relationships between masculinity variables and CRC
screening adherence also were examined in this study. Contrary to hypotheses, cancer
fear did not partially mediate the relationship between risk-taking and CRC screening
adherence. Masculinity theory suggests that men who hold risk-taking beliefs may not
feel that CRC or other diseases are a threat to their well-being (Courtenay, 2000a, 2000b,
2011; Nicholas, 2000). In addition, due to beliefs regarding the importance of
suppressing emotions, it may be that men adhering to risk-taking and other masculinity
ideals are not willing to endorse emotions such as fear (Brannon, 1976; Millar & Houska,
2007; Parent & Moradi, 2009; Walker, Tokar, & Fischer, 2000).
To the author’s knowledge, the relationship between the masculinity ideal of risktaking and cancer fear has not been previously examined among men. Regarding the
relationship between fear and cancer screening, prior studies have revealed mixed results,
largely depending upon whether general cancer fear, fear of a specific cancer type (e.g.,
breast cancer fear), or trait fear was examined (Consedine, 2012; Consedine et al., 2004;
Consedine et al, 2006; Hay, Buckley, & Ostroff, 2005; Kleier, 2010). Additionally, many
studies of cancer fear have featured female participants (Consedine et al., 2004; Hay,
Buckley, & Ostroff, 2005) and, to the author’s knowledge, none have examined CRC
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screening. Although general cancer fear has been positively associated with other types
of cancer screening (Consedine et al., 2004), it was not associated with CRC screening
adherence in this study. It is possible that these variables are not related, or that CRCspecific fear may be more closely related to CRC screening behavior.
The null mediation finding with respect to cancer fear has several potential
explanations. First, it is possible that other variables (e.g., cancer fatalism, comfort with
receipt of CRC screening test procedures or lack of embarrassment, perceptions of
normative health behaviors, and negative attitudes toward accessing healthcare) may
better account for the relationship between risk-taking and CRC screening status than
cancer fear (Consedine, Ladwig, Reddig, & Broadbent, 2011; Consedine, Reddig,
Ladwig, & Broadbent, 2011; Levant et al., 2013; Mahalik, Burns, & Syzdek, 2007;
Shelton et al., 2011). These potential mediators were not assessed in the current study
and deserve consideration for future research. In addition, the analyses may have lacked
statistical power to detect mediation due to lower numbers of non-adherent individuals in
the sample.
Also contrary to hypotheses, age did not moderate the strength of the relationship
between cancer fear and CRC screening adherence. It was hypothesized that cancer fear
would be a weak predictor of CRC screening among older participants based on prior
research with cancer survivors in which fear of death and fear of cancer recurrence
showed inverse associations with age (Cicirelli, 2006; Crist & Grunfeld, 2013; Lebel,
Beattie, Arès, & Bielajew, 2013; Ziner et al., 2012). To the author’s knowledge, age has
not been examined as a moderator of relationships between fear and any type of cancer
screening in prior research. However, in a recent study, greater fear of a CRC diagnosis
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predicted non-receipt of CRC screening among older, but not younger adults in Spain
(e.g., age 50-59 vs. 60 and over) (Molina-Barceló, Salas-Trejo, Peiró-Perez, Vanaclocha,
Pérez, & Castán, 2014). Thus, the extent to which age moderates the relationship
between cancer fear and cancer screening deserves further study. Although not
considered as moderators in prior literature, it is also possible that other variables may
moderate the relationship between cancer fear and CRC screening (e.g., perceived risk of
CRC, family history of CRC screening, prior physician recommendation for CRC
screening, self-efficacy for test completion) (Beydoun & Beydoun, 2008; Brouse et al.,
2008; Centers for Disease Control and Prevention, 2012b; Farmer et al., 2008; Friedman
et al., 2004; Guessous et al., 2010; Halbert et al., 2011; Honda, 2004; Jandorf et al., 2010;
Kremers et al., 2000; Myers et al., 1994; Post et al., 2008; Tabbarah et al., 2005; Tessaro
et al., 2006). Given variability in the relationship between fear and cancer screening,
exploring potential moderators of this relationship is an important direction for future
research (Consedine, 2012; Consedine et al., 2004; Consedine et al, 2006; Hay, Buckley,
& Ostroff, 2005; Kleier, 2010).
This study also examined whether trust in PCP accounted for the relationship
between the masculinity ideal of self-reliance and CRC screening adherence.
Masculinity theory suggests that men who endorse self-reliance ideals may avoid
healthcare services and therefore may not have the opportunity to develop a relationship
of trust with a healthcare provider and receive a recommendation for CRC screening
(Boman & Walker, 2010; Hammond, Matthews, & Corbie-Smith, 2010; Iwamoto et al.,
2011; Locke & Mahalik, 2005; Mahalik et al., 2006; Mahalik et al., 2003; Pachankis et
al., 2011; Pleck et al., 1993; Wade, 2009). Indeed, a negative relationship between self-
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reliance and trust in one’s PCP was found in the current study, suggesting that men who
believe that “real men” should be self-reliant may be less likely to trust a healthcare
provider. However, in the current study, trust in PCP was not associated with CRC
screening adherence, which contrasts with prior findings among low-income, non-veteran
patients (Greiner et al., 2005). Also, contrary to hypotheses, trust in PCP did not partially
mediate the relationship between self-reliance and CRC screening adherence. These null
findings may have been due, in part, to a restriction of range in the trust in PCP variable
with most participants endorsing a high level of trust in their provider. As the study took
place immediately prior to a primary clinic appointment, it is possible that participants
did not feel comfortable revealing low levels of trust in their provider. In addition,
veterans who were seeing a provider for the first time on the date of consent may have
been reporting their level of trust in the healthcare system in general or a previous
provider, which may have influenced study results. Additionally, other variables
associated with CRC screening adherence in prior literature such as comfort with
receiving a physical examination (e.g., lack of embarrassment) or self-efficacy for test
completion may better explain the relationship between self-reliance and CRC screening
adherence (Consedine, Ladwig, Reddig, & Broadbent, 2011; Consedine, Reddig, Ladwig,
& Broadbent, 2011; Halbert et al., 2011; Kremers et al., 2000; Myers et al., 1994; Tessaro
et al., 2006). Furthermore, it is possible that trust in PCP was mediating the relationship
between self-reliance and CRC screening adherence, but the analyses may have lacked
statistical power to detect mediation due to lower numbers of non-adherent individuals in
the study.
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Contrary to hypotheses, race did not moderate the strength of the relationship
between trust in PCP and CRC screening adherence. It was hypothesized that race might
affect the relationship between trust in PCP and CRC screening; specifically, it was
expected that the relationship between trust in PCP and CRC screening would be stronger
among African Americans compared to Whites. Especially among ethnic minority
populations, lack of trust in the healthcare system has been indicated as a barrier to
receiving preventive health services (Fyffe, Hudson, Fagan, & Brown, 2008; Greiner,
Born, Nollen, & Ahluwalia, 2005; Hammond, Matthews, Mohottige, Agyemang, &
Corbie-Smith, 2010; Jones, Devers, et al., 2010). However, this study and prior research
have not supported this hypothesis. For example, in one study, race (African American
vs. White) and trust in PCP did not significantly interact to predict receipt of prostatespecific antigen tests (Musa et al., 2009). In the current study, several factors may have
reduced statistical power for testing moderation, including the relatively small sample of
African Americans and range restriction with respect to the trust in PCP variable. In
addition, other variables not previously considered as moderators may affect the
relationship between trust in PCP and CRC screening adherence (e.g., patient-provider
racial concordance, patient-provider gender concordance) (Bonds, Foley, Dugan, Hall, &
Extrom, 2004; Menees, Inadomi, Korsnes & Elta, 2005; Saha, Komaromy, Koepsell, &
Bindman, 1999) and deserve exploration in future research.
Also contrary to hypotheses, length of patient-provider relationship did not
moderate the strength of the relationship between trust in PCP and CRC screening
adherence. Based upon patient trust theory which suggests that interpersonal trust in
one’s PCP is developed through multiple interactions with a PCP and evaluation of the
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PCP’s behavior throughout these interactions (Pearson & Raeke, 2000), it was
hypothesized that the relationship between trust in PCP and CRC screening would be
stronger with increasing length of patient-provider relationship. To the author’s
knowledge, length of patient-provider relationship had not been previously examined as a
moderator of the relationship between trust in PCP and health behaviors in any
population. The current study findings suggest that length of patient-provider
relationship may not moderate the relationship between trust in PCP and CRC screening.
However, null findings may have been due to a restriction of range in the trust in PCP
variable as well as the length of patient-provider relationship variable. For example, a
physician who carried a large patient panel left the PCP clinic soon after the current study
began. Thus, many patients had only recently begun seeing their current provider.
Specifically, 50 participants were scheduled for their initial PCP visit at the time of
consent. In addition, 28 participants did not have a current PCP assigned at the time of
consent. All of these contextual factors might have affected the relationships among
study variables.
Relationships between study covariates (i.e., age, education level, and race) and
CRC screening adherence also were examined. As has been demonstrated in prior
literature (Beydoun & Beydoun, 2008; Cokkinides et al., 2003; Tessaro et al., 2006),
increasing age was associated with a greater likelihood of being adherent to CRC
screening guidelines. Older individuals may have had more opportunities to receive CRC
screening and may have had increased awareness of their risk for CRC. Contrary to prior
literature (Beydoun & Beydoun, 2008; Cokkinides, Chao, Smith, Vernon, & Thun, 2003;
Halbert et al., 2011), lower levels of education were associated with a higher likelihood
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of CRC screening adherence in the majority of regression analyses. However, higher
levels of education were associated with an increased likelihood of CRC screening in
bivariate analyses and the mediation and moderated-mediation models. Of note, the use
of the bootstrapping method as well as the inclusion of other variables in the models may
have contributed to a change in the direction of the association between education level
and CRC screening adherence across mediation analyses. In addition, race was not a
significant predictor of CRC screening adherence in regression analyses or bivariate
analyses. If the current study had included veterans accessing healthcare services as well
as those not currently accessing healthcare services, race may have been more predictive
of CRC screening adherence. Among veterans, race and CRC screening adherence have
shown differential associations across studies (Burgess et al., 2011; Dolan et al., 2005).
For example, in a mail-based study of African American and White veterans from 24
different VA Medical Centers, White race was associated with CRC screening adherence
prior to controlling for other demographic and cognitive variables (Burgess et al., 2011).
Conversely, in a study of veterans accessing services in a VA primary care clinic, African
Americans were more likely to adhere to CRC screening guidelines than Whites (Dolan
et al., 2005). Interestingly, in the former study, CRC screening adherence rates were
higher among Whites who were married and well-educated and higher among African
Americans who were unmarried and had lower levels of education (Burgess et al., 2011).
Thus, the examination of demographic subgroups (e.g., interactions between race and
marital status) may be informative in future research which features larger samples of
ethnic minority individuals.
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Furthermore, the relationships between CRC screening adherence and physician
recommendation and family or friend recommendation for CRC screening were
examined, as these variables have been associated with CRC screening adherence in
previous studies (Gilbert & Kanarek, 2005; Taylor et al., 2003). Consistent with prior
literature (Gilbert & Kanarek, 2005; Taylor et al., 2003), bivariate analyses suggested a
positive association between CRC screening adherence and physician recommendation
for CRC screening. However, physician recommendation was negatively associated with
CRC screening adherence in one set of regression analyses. These findings may be have
been due to the use of the bootstrapping method and the presence of other variables in the
model. Family and friend recommendation for CRC screening showed a significant,
positive association with CRC screening adherence in bivariate analyses, but was not a
significant predictor in the regression analyses. In prior research, family or friend
encouragement for receiving CRC screening has been associated with greater odds of
being at a higher stage of adoption for both FOBT and colonoscopy (Wang et al., 2014).
In addition, greater perceived family member or friend support for CRC screening
predicted CRC screening adherence in men and women attending Appalachian churches
(Tessaro et al., 2006). However, in a study conducted among low-income and
predominantly African-American individuals who were non-adherent to CRC screening
guidelines at the time of receiving a CRC screening intervention, there was no significant
relationship between family member or friend recommendation for CRC screening and
CRC screening behavior (Brouse et al., 2008). Social factors (e.g., marital status, number
and quality of friendships) might help explain variability in relationships between
family/friend CRC screening recommendation and screening behaviors. Of note, in the
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current study, a lower percentage of men were married compared to the general
population of men of their age (U.S. Census Bureau, 2012), and being married has been a
significant predictor of CRC screening in prior literature (Guessous et al., 2010). Future
studies might consider the closeness of the relationship as well as the type of relationship
(e.g., spouse, child, friend, sibling) between the patient and the person who has
recommended CRC screening when predicting CRC screening adherence.

Potential Explanations for Study Results
Several sample characteristics may have contributed to null study results. First,
study participants were veterans accessing primary care services within a VA hospital.
Veterans represent a unique sector of the United States population in that those with an
honorable discharge from the military are eligible for low-cost or free healthcare services
at VA Medical Centers (Morgan, Teal, Reddy, Ford, & Ashton, 2005). Compared to the
general population of adults in the U.S. and veterans who do not access healthcare
through the VA system, veterans accessing care at VA Medical Centers are less likely to
be employed and are more likely to be older, to self-identify as African American, to
have lower levels of income and education, and to have more medical and mental health
diagnoses (Morgan et al., 2005). Furthermore, veterans accessing healthcare services
may differ from those unwilling to see a PCP with respect to masculinity beliefs and
other characteristics. If the present study had been conducted among individuals who
were not currently accessing healthcare services or those who had not seen a PCP for
preventive care in the past several years, results may have revealed different relationships
between study variables (e.g., masculinity beliefs, trust in PCP, and CRC screening

63
adherence). In addition, there was a restriction of range in responses to two of the three
masculinity subscales, as few men had masculinity scores at the upper end of the scale.
For example, the mean score on the self-reliance scale was 1.24 and the highest mean
score was 2.40, although the scale maximum is 3.0. Similarly, the mean score on the
risk-taking scale was 1.10, with few individuals reporting the maximum score of 3.0. Of
note, the sample consisted of middle-age and older men (i.e., 51-75 years), and
masculinity beliefs have been found to decline with increasing age (Terracciano, McCrae,
& Costa, 2006). Declining masculinity beliefs with increasing age may be due to poorer
health and greater dependency on health care and other services to fulfill one’s needs.
Finally, it is possible that study refusals or missing data may have been related to literacy
and/or health literacy issues; however, literacy and health literacy were not assessed
during the study.
Study findings may also be related to several VA system-level factors. First, in
recent years, there has been a system-wide emphasis on increasing CRC screening
adherence rates among veterans (Chao et al., 2009; Jackson et al., 2010). A successful
national initiative to improve CRC screening rates at VA Medical Centers in the last
several years included electronic medical record reminders as well as performance
incentives for physicians (Chao et al., 2009). These efforts may have led to increased
patient awareness of CRC screening which may have impacted screening rates, making it
more difficult to recruit non-adherent individuals. Lower numbers of non-adherent
veterans in this study may have reduced statistical power for detecting effects.
Furthermore, men who continue to be non-adherent in the VA healthcare system may
differ on important characteristics from non-adherent men who do not access VA
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services. Another VA system-level factor that may have influenced study results was
recruitment for a large, national randomized controlled trial comparing the efficacy of the
FIT test to colonoscopy in the same primary care clinics as the current study. The
ongoing recruitment for that study may have influenced our consent rates and study
results. Specifically, some veterans may have confused the nature of the current study
(i.e., study questionnaire only) versus the randomized controlled trial (i.e., intervention
with CRC testing), which may have reduced the consent rate. It is also possible that,
among veterans who were non-adherent to CRC screening, those who declined the
current study held different beliefs about CRC screening or other study variables than
those who agreed to participate. A third system-level factor potentially influencing study
results is that many individuals had experienced a recent change in their PCP. Some
participants had recently begun to receive care at the VA, whereas others had recently
switched providers within the hospital. During the study, one long-time PCP with a large
patient panel left the main clinic where recruitment took place, and his patients were
either without a listed PCP or had been recently transferred to other providers whom they
may or may not have met previously. Indeed, for 50 participants, the date of consent was
their first visit to the provider, and 28 participants were not yet assigned to a regular PCP
at the time of consent. Thus, a change in providers may have contributed to null findings
in this study, such as the lack of relationship between trust in one’s PCP and CRC
screening adherence.
Furthermore, study design issues may have influenced study results. First, the
research assistants for the study were both female. The gender of the research assistants
may have led to lower levels of consent among some men as well as socially desirable
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responses from study participants. Prior research has demonstrated that the gender of
research assistants conducting study interviews may influence participant responses
(Davis, Couper, Janz, Caldwell, & Resnicow, 2010). Specifically, in prior research about
gender roles and characteristics (e.g., masculinity and femininity), response biases that
were “more socially progressive responses or responses that deferred to the interviewer's
gender” were revealed among participants of both genders responding to male versus
female interviewers (Davis, Couper, Janz, Caldwell, & Resnicow, 2010, p. 22). For
example, one telephone survey found that male participants who were more highly
educated and reported being low in power in their romantic relationship endorsed more
liberal gender role views to a female research assistant than those interviewed by a male
research assistant (Lueptow, Moser, & Pendleton, 1990). It is unclear whether or how the
gender of research assistants in the current study may have influenced responses to the
masculinity variables. Although the questionnaire was self-administered, the informed
consent process was conducted in-person, and participants gave their paper questionnaire
directly to the female research assistant. One veteran who refused to participate in the
study mentioned his discomfort with discussing the topic of CRC screening with a female
research assistant.
In addition, despite the confidential nature of the study, participants may not have
felt comfortable providing honest responses to the masculinity questions which broached
potentially sensitive topics (e.g., beliefs about power over women and heterosexual selfpresentation). Multiple participants wrote comments such as “I’m not gay” in the
margins of the survey near the heterosexual self-presentation masculinity subscale items
demonstrating awareness (and perhaps concern) that their responses would be reviewed.
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Second, the study was conducted in the primary care clinic just prior to the patient’s visit
with his provider, which may have resulted in response biases. As noted previously,
there was a restriction of range in the trust in PCP variable, with the majority of
individuals indicating high levels of trust in their healthcare provider. Third, in addition
to using medical record review, the current study relied upon self-report measures of
CRC screening adherence, which may have contributed to reponse biases and
inaccuracies. There were 56 instances of incongruence between the medical record and
self-reported CRC screening status. Specifically, 46 participants reported that they were
up-to-date with CRC screening which was not supported by medical record
documentation, and 10 participants reported that they were non-adherent which was not
supported by medical record documentation.
Measurement issues may have also influenced study results. First, the current
masculinity scale was not initially validated in samples of older adults or veterans.
Instead, the masculinity scale had been normed with male college students (Parent &
Moradi, 2009; Parent & Moradi, 2011; Parent, Moradi, Rummell, & Tokar, 2011) who
may respond differently to items as compared to older male veterans. However, the
questionnaire has subsequently been administered to both undergraduate and communitydwelling men aged 18 to 63 (Levant & Wimer, 2014a), men aged 22 to 78 who have sex
with men (Parent, Torrey & Michaels, 2012), and men and women aged 18 to 83 (Parent
& Smiler, 2013). To the author’s knowledge, the present study represents the first time
that the masculinity scale was administered to veterans. In addition, the masculinity
scales assessed general masculinity beliefs without referring to masculinity in relation to
a healthcare context. For example, the scales do not assess masculinity beliefs related to
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screening tests or medical services which breach physical boundaries. These beliefs may
be more proximal to CRC screening behavior. For example, if the current study had
utilized an item such as “a colonoscopy can affect masculinity” (modified from an item
designed by Paiva et al., 2011), a significant relationship between CRC screening
adherence and this belief may have been found. Taken together, characteristics of the
measures, sample, VA system, and study design may have affected the response rate,
accuracy of study data, and ability to attain statistical significance.

Limitations
Limitations of this study should be noted. First, the study features a crosssectional design and, thus, causal relationships and changes in beliefs and behaviors over
time could not be examined. Indeed, it may be that study variables such as masculinity
beliefs and CRC screening adherence would be correlated longitudinally, although they
were not related in this cross-sectional study. Second, veterans who agreed to participate
in this study may have differed in important ways from those who declined participation,
especially with respect to CRC screening adherence. These differences may have
contributed to less variability in responses to study questionnaires. However, the
percentage willing to undergo eligibility screening (73% of those approached) was
comparable to that of prior research on veterans’ CRC screening adherence. For
example, a cross-sectional survey on CRC screening among non-adherent veterans
conducted in clinic yielded a 74% participation rate (Dolan et al., 2004). Another study
of CRC screening conducted via mailed survey yielded a slightly higher participation rate
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of 81% with differential response rates between African American and White VA
patients (i.e., 73% for African American veterans and 89% for White veterans).
Third, variables which may be related to masculinity ideals, such as willingness to
access healthcare services, perceptions of normative health behaviors, perceived barriers
to accessing healthcare, self-efficacy, and gender role stress were not included in study
analyses (Levant & Wimer, 2014b; Mahalik, Burns, & Syzdek, 2007). Indeed, a recent
study demonstrated that general self-efficacy and perceptions of normative health
behaviors partially mediated the relationships between masculinity ideals (i.e., the
CMNI-46 total score which includes 9 masculinity beliefs) and health behaviors (i.e.,
Health Behavior Inventory-20 total score which includes a range of health-promoting and
health-risk behaviors) (Levant & Wimer, 2014b; Levant, Wimer, & Williams, 2011).
Fourth, the study relied upon self-report measures. It is possible that participants
provided inaccurate responses due to social desirability, poor literacy, or, more
specifically, poor health literacy; however, CRC screening tests were described in
layperson’s terms on the study questionnaire. Fifth, participants’ medical comorbidities
were not assessed, as the relationship between comorbidities and CRC screening has been
inconsistent (Fleming et al., 2011; Lukin et al., 2012). However, comorbidity coupled
with increasing age may affect whether a patient receives a CRC screening
recommendation as well as the test modality (i.e., FOBT or FIT vs. colonoscopy)
recommended by his PCP (Haggstrom, Klabunde, Smith, & Yuan, 2013). In addition, of
note, a lower percentage of men in the current study reported being married compared to
men in the United States population of similar age (e.g., 55% in the current study vs. 7078% for United States men age 45-74) (U.S. Census Bureau, 2012). The relationship
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between marital status and CRC screening adherence was not examined in the current
study. However, in multiple prior studies, being married has generally been associated
with CRC screening adherence, but has not consistently predicted this outcome
(Guessous et al., 2010; Patel et al., 2013; Shires et al., 2011; van Jaarsveld, Miles,
Edwards, & Wardle, 2006; Weiss et al., 2013).
Sixth, general cancer fear rather than CRC-specific fear was assessed.
Furthermore, fear of CRC screening methods was not measured, which has been
predictive of screening behavior in prior studies (Jibara, Jandorf, Fodera, DuHamel,
2011; Lee, Consedine, & Spencer, 2011). Finally, the majority of the sample selfidentified as White, and the sample was limited to male veterans who were engaged in
PCP services and receiving their care at a single Midwestern VAMC, which limits
generalizability to dissimilar populations. Veterans represent a unique population of
individuals who, depending upon their circumstances, have access to PCP and CRC
screening services at little or no cost. Thus, findings may not generalize to non-veterans,
men who do not have a regular PCP or readily available access to CRC screening
services, women, and those from racial minority groups.

Future Research Directions and Recommendations
Based on the study findings, a number of future research directions warrant
consideration. First, in order to test masculinity theory in a healthcare context, measures
assessing masculinity beliefs as they relate to the receipt of healthcare services, including
CRC screening, should be developed (e.g., items such as “a real man does not allow a
doctor to exam his body” or “a real man does not let a doctor insert objects into his
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rectum as part of a medical test”). As noted previously, the current masculinity measure
assessed general beliefs that may be less predictive of CRC screening adherence or
medical care use compared to more specific masculinity beliefs related to healthcare.
Second, longitudinal studies are needed to assess potential changes in masculinity
beliefs as men age and their relationship to the use of healthcare services in VA and nonVA settings. In a longitudinal study of personality, scores on the masculinity scale of the
Guilford-Zimmerman Temperament Survey were found to decline with increasing age in
a linear fashion over a 42 year period among both men and women (Terracciano,
McCrae, & Costa, 2006); however, this study was not conducted with veterans and
correlates of this decline were not assessed. Masculinity beliefs theoretically associated
with healthcare receipt (i.e., self-reliance, heterosexual self-presentation, risk-taking) may
be expected to change as men access more health services. For example, as men place
greater trust in their providers based upon more frequent interactions with them, a sense
of self-reliance may decline.
In addition, the hypotheses of the current study should be tested in different
populations. For example, the study should be conducted with a more ethnically diverse
sample, as participants in the current study were generally White or African American.
Future studies should recruit participants from other ethnic groups to assess whether
between-group differences in relationships between masculinity beliefs and CRC
screening adherence exist. In qualitiative studies, many of the men reporting concerns
about the maintenance of masculinity in the context of invasive cancer testing were from
minority groups (e.g., African American and Latino or Hispanic men) (Bass et al., 2011;
Beeker et al., 2000; Getrich et al., 2012; Harvey & Alston, 2011; Holt et al., 2009;
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Rivera-Ramos & Buki, 2011; Thompson et al., 2011; Winterich et al., 2009). Thus,
research studies should examine masculinity beliefs and related cultural beliefs that may
impact CRC screening adherence and other health behaviors in specific minority groups.
In addition, this research should be extended to non-veterans and men who do not
regularly use primary care services, as their masculinity beliefs and CRC screening
adherence may differ from those of veterans who regularly use primary care services.
Finally, further research is necessary to explore a range of theory-driven mediators and
moderators of relationships between masculinity beliefs and CRC screening.

Conclusions
Qualitative studies have suggested that some men believe that medical tests
involving the rectum may be an affront to commonly-held masculinity ideals. The
current quantitative study aimed to examine the relationship between the masculinity
beliefs of risk-taking, self-reliance, and heterosexual self-presentation and colorectal
cancer screening behaviors among male veterans accessing primary care services. These
masculinity variables were not significantly associated with CRC screening adherence in
correlational and logistic regression analyses.
Results of the present study lead to a number of research questions to be
examined in future research. Relationships between study variables should be examined
in a population not actively accessing healthcare services. In addition, as mentioned,
these research questions should be examined among specific minority groups (e.g.,
African-American and Latino men) to better understand relationships between study
variables and cultural beliefs which may be associated with healthcare beliefs,
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masculinity ideals, and health behaviors. Furthermore, future studies should include nonveteran samples, as their masculinity ideals and healthcare use beliefs and behaviors may
differ from those of veterans. In addition, future studies should develop and utilize
masculinity measures which assess beliefs more proximal to receiving CRC screening
and other healthcare. Finally, prospective and longitudinal research studies are needed to
better understand relationships among study variables.
If masculinity beliefs are found to be related to CRC screening adherence in
future studies, gender-specific CRC screening interventions could be developed that
address values important to men in order to foster CRC screening adherence
(Friedemann-Sanchez et al., 2007). For example, men could receive tailored messages
which encourage CRC screening in order to maintain masculinity norms that are
important to them (e.g., maintain one’s health in order to support one’s family) (O'Brien,
Hunt, & Hart, 2005). In addition, study findings could be applied to research regarding
other preventive health behaviors among men.
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Table 1. Quotations from qualitative studies reflecting masculinity norms and cancer
screening involving the rectum
Quotation:
…probing around in my rectum . . . [is] treading
on my masculinity.
I think there’s an aspect that people think it’s gay
and there’s that whole sexual issue about it. If
you’re willingly to submit to doing this thing, you
could never tell anyone about it. . .So I am
wondering if it’s part of this homosexual thing or
this fear of having a digital rectal exam or having
someone messing around your butt. Maybe I have
some questions about my own sexuality, my own
sexual orientation. What do I do if I like it? What
if I find out something about myself while I’m
having this exam? Or what if I have questions
about myself, what if I’m insecure and that’s what
keeps me from going to have this exam. How do
you address that insecurity if it’s sexual identity
or sexual orientation?
Demeaning…[because] that’s where you’re most
vulnerable.
The myth about that type of procedure—
they always relate it to a sexual encounter. You
do
not want nobody to fool around your butt because
they might think they are bisexual.
…you know, guys are usually reluctant to have
colonoscopies because I guess it is a male ego
thing you know, having something inserted into
your rectum.
…like a taboo. [People] don’t want the doctor to
insert the finger. That’s what a lot of people have
on their minds.
…compromised position…(where)…you’re
pretty much at the mercy of somebody.
…biggest fear…someone placing something in
my rectum, that’s how most men are.
You might want to call me old school…certain
part of the body wasn’t made for entrance in a
man [laughs].

Participant
characteristics if
known:
AfricanAmerican man
under age of 65
AfricanAmerican man

Source:

Caucasian man
AfricanAmerican man

Winterich et al.,
2011, p. 531
Holt et al., 2009,
p. 881

AfricanAmerican man

Bass et al., 2011,
p. 124

MexicanAmerican man

Getrich et al.,
2012, p. 8

Caucasian man

Winterich et al.,
2011, p. 531
Winterich et al.,
2009, p. 6
Winterich et al.,
2011, p. 531

AfricanAmerican man
AfricanAmerican man

Beeker et al.,
2000, p. 268
Harvey &
Alston, 2011, p.
147
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Table 1, continued.
If you were a man, you didn’t do that….Hey, you
don’t get any hand put up your butt.

AfricanAmerican man

But the other thing is women are better than men,
I’m afraid, at dealing with these things. Men are
um (.) I was going to say phobic, if you like. I
was going to take it one step further and [say] …
homophobic, if you like, because, you know,
you’re talking about men’s bottoms and that sort
of thing. Do you know what I mean?
It is not so much the worry. It is the intrusion
part…It is just in my make up. It is an intrusion to
keep having to go in a man’s rectum.
I think it’s problematic for men…especially
homophobic men…they think you let someone do
that to you, you ain’t a real man.
I’m sorry, I don’t mean to interrupt, but let's get
real. The myths about a lot of black males are that
to protect that macho image, you don’t have
anybody messing around with your butt.
[My friend] told me he had lost his manhood. So,
we must be very careful with that because people
think that they lose their manhood
[Men's] attitudes [toward the DRE] are not the
best… because sometimes they do things that
[physically] hurt more [than the DRE]. But, the
fact is that it is an uncomfortable experience
because they do it in a [body] part where it is not
usual for a man to [get examined]. And yes, as
liberal as I may be, I still do not like to be touched
in that [body] part; even if it's once a year.
Just part of the body guys feel uncomfortable
about.
Men don’t like for anyone to touch them there.
The same goes for me. That’s why I hadn’t gone
over there [in Mexico]. I spent lots of effort
[there] protecting [my sexuality] just to give it up
in the United States [laughs].
An insult to my manhood….(And the reason that
you don’t like the finger test is because of the
invasiveness?) Invasiveness, and maybe just call
me homophobic. I don’t play that. I’m the
screwer, not the screwee.

Man from New
Zealand

Harvey &
Alston, 2011, p.
147
Thompson et al.,
2011, p. 9-10

AfricanAmerican man

Bass et al., 2011,
p. 124

Man from
Virginia, USA

Jones, Devers, et
al., 2010, p. 512

AfricanAmerican man

Harvey &
Alston, 2011, p.
147

Latino man

Rivera-Ramos &
Buki, 2011, p. 20

Latino man

Rivera-Ramos &
Buki, 2011, p. 20

Caucasian man

Winterich et al.,
2009, p. 5
Getrich et al.,
2012, p. 8

Man from
Mexico living in
the United States

AfricanAmerican

Winterich et al.,
2009, p.7
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Table 1, continued.
Violated…men don’t like for people going up
in…the rectum… I’m a man, and I just don’t feel,
I don’t feel comfortable like that!
Something’s up in your rectum would be kind of
a compromised position for me.
Certain parts of the body weren’t made for
entrance in a man.
I think probably a lot of them feel the same way I
do about it, it’s not very comfortable, kind of
embarrassing….(And why do you think they feel
that way?)…I just think it’s the way that men are
probably brought up, and, you know, raised up as
to…be exposed to another man like that in that
kind of setting.
I hate it. It’s one of the most dangerous tests a
doctor can give me. For him. (For him?) Yeah.
Because it depends upon my mental state how I
am going to respond to that test. Hopefully my
mental state is analytical, scientific, and within
control. I don’t want it to be in my normal
reaction of protection. Because I may be old but
even old rattlesnakes can kill you (laughs).
It’s kind of always hard for macho guys, you
know, shoving this thing up your butt, is not
something that everyone really looks forward to.
Most guys . . . the reason they don’t have it
[screening] is because first they’s gonna think
about somebody is going to be violating them and
going up their rectum.

AfricanAmerican man

Winterich et al.,
2009, p. 5

Caucasian man

Winterich et al.,
2009, p. 6
Winterich et al.,
2009, p. 6
Winterich et al.,
2009, p. 7

AfricanAmerican man
Caucasian man

AfricanAmerican man

Winterich et al.,
2009, p. 8

Man from USA

Wackerbarth et
al., 2005, p. 547

Man from USA

Pitts et al., 2013,
p. 84
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Table 2. Sample characteristics (N = 327)
Demographic variable
Age
Length of relationship with PCP (in months)
Race

White
Black or African-American
Asian-American/Pacific Islander
Native American
Hispanic/Latino
Other/More than one race

Descriptive statistics
M (SD), Range
61.9 (5.8), 51-75
48.5 (46.57), 0-199
% (n)
73 (238)
21 (68)
<1 (2)
2 (7)
<1 (1)
3 (11)

Education
HS diploma/GED or less
36 (119)
Some college or greater
64 (208)
Employment status
Unemployed/Retired
69 (226)
Employed
31 (101)
Income
$30,999 or less
59 (194)
$31,000 or greater
41 (133)
Marital status
Single, separated, divorced
40 (131)
Married
55 (179)
Widowed
5 (17)
Health insurance status
Yes
41 (135)
No
59 (192)
Gender of PCP
Male
41.3 (135)
Female
50.2 (164)
Missing
8.6 (28)
Physician recommendation for CRC screening
Yes
91 (297)
No
9 (30)
Family/friend recommendation for CRC screening
Yes
55 (181)
No
45 (146)
Note: HS = high school; GED = General Education Development; PCP = primary care
provider; CRC = colorectal cancer

-

1

1.79 (0.64),
0-3.0

1.24 (0.47),
0-2.4

6. Self-reliance

73 (238)

4. Race3

5. Heterosexual
self-presentation

64 (208)

-.087

.003

.101

.127*

61.9 (5.82), .230**
51-75

65 (213)

3. Education
level2

1. CRC
screening
status1
2. Age

% (n) or
Mean (SD),
Range

-.070

-.025

.126*

.063

-

2

Table 3. Intercorrelations among study variables

-.040

-.168**

.023

-

3

.101

-.129*

-

4

.087

-

5

-

6

7

8

9

10

11

107

.117*

.346**

-.052

-.008

.013

1

.090

.062

-.011

-.111*

.008

.135*

3

.070

-.046

-.014

-.005

2

-.107

.067

.010

-.037

.147**

4

-.058

-.069

.069

.011

-.135*

5

SD = standard deviation; CRC = colorectal cancer; PCP = primary care provider

Significant results are displayed in bold.

Note. N = 327; **p < 0.01 and *p < 0.05.

55 (181)

11. Family/friend
recommend.5

2.76 (0.92),
1.0-5.0

9. Cancer fear

91 (297)

4.13 (0.91),
1.2-5.0

8. Trust in PCP

10. Physician
recommend.4

1.10 (0.45),
0-3.0

% (n) or
Mean (SD),
Range

7. Risk-taking

Table 3, continued.

-.020

-.035

.135*

-.159**

.129*

6

-.007

-.052

-.044

-.093

-

7

-.154**

-.072

-.101

-

8

.130*

.015

-

9

.119*

-

10

-

11
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C RC screening status coded as 0 = no and 1 = yes.

Education level coded as 0 = HS diploma or GED or less and 1 = some college or more.

Race coded as 0 = minority race and 1 = White race.

Physician recommendation for CRC screening coded as 0 = no and 1 = yes.

Family/friend recommendation for CRC screening coded as 0 = no and 1 = yes.

1

2

3

4

5

Table 3, continued.
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Block 2

Block 1

Block 2

Block 1

Wald chiVariables
B
SE
square
(df=1)
Heterosexual self-presentation model
1
Race
-0.342
0.265
1.670
Age
0.022
14.668
0.083**
2
Education level
0.246
4.451
-0.518*
Constant
1.334
9.703
-4.155*
1
Race
-0.366
0.268
1.867
Age
0.022
14.668
0.083**
2
Education level
0.250
4.800
-0.547*
Heterosexual self- 0.132
0.193
0.470
presentation
Constant
1.378
10.107
-4.382**
Self-reliance model
1
Race
-0.342
0.265
1.670
Age
0.022
14.668
0.083**
2
Education level
0.246
4.451
-0.518*
Constant
1.334
9.703
-4.155*
1
Race
-0.394
0.268
2.159
Age
0.022
13.990
0.081**
2
Education level
0.246
4.294
-0.511*
Self-reliance
-0.383
0.262
2.135
Constant
1.394
6.566
-3.572*
0.710
1.086
0.595
0.016
0.674
1.085
0.600
0.682
0.028

0.012

0.710
1.086
0.595
0.016
0.694
1.086
0.579
1.141

Odds
ratio

0.399-1.141
1.039-1.132
0.370-0.973
0.408-1.140

0.422-1.194
1.041-1.133
0.368-0.964

0.410-1.172
1.041-1.133
0.355-0.944
0.782-1.666

0.422-1.194
1.041-1.133
0.368-0.964

95% CI for odds
ratio

Table 4. Logistic regression analyses predicting colorectal cancer screening adherence as a function of masculinity norms (Aim 1)
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Variables

SE

Risk-taking model
-0.342
0.265
0.022
0.083**
0.246
-0.518*
1.334
-4.155*
-0.351
0.268
0.022
0.082**
0.248
-0.525*
-0.061
0.276
1.381
-4.075*

B

1.670
14.668
4.451
9.703
1.715
14.612
4.494
0.049
8.701

Wald chisquare
(df=1)
0.710
1.086
0.595
0.016
0.704
1.086
0.591
0.941
0.017

Odds
ratio

Education level coded as 0 = HS diploma or GED or less and 1 = some college or more.

2

CI = confidence interval; SE = standard error

Race coded as 0 = minority race and 1 = White race.

1

Significant results are displayed in bold.

0.416-1.190
1.041-1.133
0.364-0.961
0.548-1.616

0.422-1.194
1.041-1.133
0.368-0.964

95% CI for odds ratio

The outcome variable, colorectal cancer screening adherence, was coded as 0 = no and 1 = yes.

Block 1

Race1
Age
Education level2
Constant
Block 2
Race1
Age
Education level2
Risk-taking
Constant
Note: N = 327; *p < .05, **p < .01.

Table 4, continued.
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Path b
B (SE)
-0.0762
(0.1304)
-0.0292
(0.1353)

Path a
B (SE)
-0.0698
(0.1172)
-0.3104
(0.1086)**

-0.0608
(0.2761)
-0.3834
(0.2624)

Path c
B (SE)
-0.0655
(0.2764)
-0.3919
(0.2655)

Path c’
B (SE)
0.0053
(0.0199)
0.0091
(0.0480)

Indirect
effect
B (SE)

Path c’ is the direct effect of the independent variable on the dependent variable.

Path c is the total effect of the independent variable on the dependent variable.

Path b is the relationship between the mediator and the dependent variable.

Path a is the relationship between the independent variable and the mediator.

CRC = colorectal cancer; PCP = primary care provider; CI = confidence interval; SE = standard error

Beta coefficients are unstandardized.

Significant results are displayed in bold.

The outcome variable, CRC screening adherence, was coded as 0 = no and 1 = yes.

Note: N = 327; **p < .01.

Self-reliance/Trust in PCP

Independent
variable/Mediator of its
effect on CRC screening
adherence
Risk-taking/Cancer fear

Table 5. Mediated model paths predicting CRC screening adherence (Aim 2)

-0.0791-0.1205

-0.0202-0.0904

95% CI for the
indirect effect
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Table 6. Cancer fear as mediator of the relationship between risk-taking and colorectal
cancer screening adherence (Aim #2, Hypothesis #2.1)

Variable
Constant
Risk-taking
Age
Race1
Education level2
Variable
Constant
Cancer fear
Risk-taking
Age
Race1
Education level2

Variable
Constant
Risk-taking
Age
Race1
Education level2

Total effect of
X on Y
Direct effect of
X on Y
Indirect effect of
X on Y
Note: N = 327

Outcome: Cancer fear
Coefficient
SE
t
p-value
3.3545
0.5615
5.9740
<0.01
-0.0698
0.1172
-0.5960
0.5516
-0.0068
0.0089
-0.7628
0.4461
0.0462
0.1170
0.3952
0.6930
-0.2007
0.1073
-1.8698
0.0624
Outcome: CRC screening adherence
Coefficient
SE
z
p-value
-4.7038
1.4227
-3.3063
0.0009
-0.0762
0.1304
-0.5843
0.5590
-0.0655
0.2764
-0.2369
0.8128
0.0821
0.0216
3.7994
0.0001
0.3540
0.2683
1.3194
0.1870
0.5112
0.2491
2.0526
0.0401
Outcome: CRC screening adherence
Total effect model
Coefficient
SE
z
p-value
-4.9512
1.3590
-3.6433
0.0003
-0.0608
0.2761
-0.2204
0.8256
0.0825
0.0216
3.8225
0.0001
0.3509
0.2679
1.3098
0.1903
0.5254
0.2478
2.1199
0.0340

95% CI
2.2498-4.4593
-0.3004-0.1607
-0.0242-0.0107
-0.1839-0.2763
-0.4119-0.0105
95% CI
-7.4922--1.9154
-0.3317-0.1794
-0.6071-0.4762
0.0397-0.1244
-0.1719-0.8799
0.0231-0.9994

95% CI
-7.6148--2.2877
-0.6019-0.4802
0.0402-0.1247
-0.1742-0.8760
0.0396-1.0111

Effect
-0.0608

SE
0.2761

z
-0.2204

p-value
0.8256

95% CI
-0.6019-0.4802

-0.0655

0.2764

-0.2369

0.8128

-0.6071-0.4762

0.0053

0.0199

0.2674

0.7892

The outcome variable, CRC screening adherence, was coded as 0 = no and 1 = yes.
Significant results are displayed in bold.
Coefficients are unstandardized.
SE = standard error; CI = confidence interval; CRC = colorectal cancer.
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Table 6, continued.
1

Race coded as 0 = minority race and 1 = White race.

2

Education level coded as 0 = HS diploma or GED or less and 1 = some college or more.
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Table 7. Trust in PCP as mediator of relationship between self-reliance and colorectal
cancer screening adherence (Aim #2, Hypothesis #2.2)

Variable
Constant
Self-reliance
Age
Race1
Education level2
Variable
Constant
Trust in PCP
Self-reliance
Age
Race1
Education level2

Variable
Constant
Self-reliance
Age
Race1
Education level2

Total effect of
X on Y
Direct effect of
X on Y
Indirect effect of
X on Y
Note: N = 327

Outcome: Trust in PCP
Coefficient
SE
t
p-value
4.7655
0.5644
8.4433
<0.01
-0.3104
0.1086
-2.8573
0.0046
-0.0036
0.0087
-0.4138
0.6793
-0.0372
0.1143
-0.3254
0.7451
0.0064
0.1045
0.0617
0.9509
Outcome: CRC screening adherence
Coefficient
SE
z
p-value
-4.3325
1.5311
-2.8297
0.0047
-0.0292
0.1353
-0.2160
0.8290
-0.3919
0.2655
-1.4762
0.1399
0.0810
0.0217
3.7295
0.0002
0.3936
0.2681
1.4680
0.1421
0.5103
0.2465
2.0706
0.0384
Outcome: CRC screening adherence
Total effect model
Coefficient
SE
z
p-value
-4.4760
1.3809
-3.2414
0.0012
-0.3834
0.2624
-1.4613
0.1439
0.0811
0.0217
3.7404
0.0002
0.3939
0.2681
1.4692
0.1418
0.5106
0.2464
2.0722
0.0382

95% CI
3.6551-5.8759
-0.5241--0.0967
-0.0208-0.0136
-0.2620-0.1876
-0.1991-0.2120
95% CI
-7.3334--1.3317
-0.2943-0.2359
-0.9123-0.1284
0.0384-0.1235
-0.1319-0.9190
0.0273-0.9933

95% CI
-7.1826--1.7695
-0.8976-0.1308
0.0386-0.1237
-0.1316-0.9193
0.0277-0.9936

Effect
-0.3834

SE
0.2624

z
-1.4613

p-value
0.1439

95% CI
-0.8976-0.1308

-0.3919

0.2655

-1.4762

0.1399

-0.9123-0.1284

0.0091

0.0446

0.2043

0.8388

The outcome variable, CRC screening adherence, was coded as 0 = no and 1 = yes.
Significant results are displayed in bold.
Coefficients are unstandardized.
SE = standard error; PCP = primary care provider; CI = confidence interval; CRC =
colorectal cancer
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Table 7, continued.
1

Race coded as 0 = minority race and 1 = White race.

2

Education level coded as 0 = HS diploma or GED or less and 1 = some college or more.

Path c’
B (SE)

-0.0881
(0.2767)
-0.4202
(0.2677)
-0.3751
(0.2657)

Path b
B (SE)

2.120
(1.463)
-0.0961
(0.2811)
-0.1131
(0.1939)

-0.89590.1456

-0.94500.1045

-0.63040.4543

0.0017
(0.0034)

0.0766
(0.3189)

-0.0360
(0.0239)

95% CI
Interaction
for Path c’
B (SE)

-0.0051-0.0084

-0.5484-0.7017

-0.0828-0.0108

95% CI for
interaction

CI = confidence interval; SE = standard error; PCP = primary care provider; CRC = colorectal cancer

Beta coefficients are unstandardized.

Significant results are displayed in bold.

Race coded as 0 = African American race and 1 = White race.

The outcome variable, CRC screening adherence, was coded as 0 = no and 1 = yes.

Independent
variable/
Path a
Mediator/
B (SE)
Moderator
Risk-taking/
-0.0670
Cancer fear/
(0.1170)
Age
Self-reliance/
-0.3143**
Trust in PCP/
(0.1078)
Race
Self-reliance/
-0.3104**
Trust in PCP/
(0.1078)
Length of
relationship
with PCP
Note: N = 327; **p < .01.

Table 8. Moderated mediation model paths predicting CRC screening adherence (Aim 3)

-0.0005
(0.0013)

-0.0241
(0.1268)

-0.0036-0.0018

-0.3176-0.2058

Moderated
95% CI for
mediation
moderated
index
mediation index
B (SE)
0.0024
-0.0050-0.0232
(0.0061)
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Path c’ is the direct effect of the independent variable on the dependent variable.

Path b is the relationship between the mediator and the dependent variable.

Path a is the relationship between the independent variable and the mediator.

Table 8, continued.
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Table 9. Moderated mediation of relationship between risk-taking and colorectal cancer
screening adherence (Aim #3, Hypothesis #3.1)
Variable
Constant
Risk-taking
Race1
Education level2
Variable
Constant
Cancer fear
Risk-taking
Age
Interaction (Cancer
fear x Age)
Race1
Education level2

Outcome: Cancer fear
Coefficient
SE
t
p-value
2.9439
0.1596
18.4459
<0.01
-0.0670
0.1170
-0.5722
0.5676
0.0348
0.1159
0.3000
0.7644
-0.2060
0.1070
-1.9243
0.0552
Outcome: CRC screening adherence
Coefficient
SE
z
p-value
-10.9344
4.4145
-2.4769
0.0133
2.1204
1.4631
1.4493
0.1473
-0.0881
0.2767
-0.3183
0.7503
0.1841
0.0718
2.5633
0.0104
-0.0360

0.0239

-1.5074

95% CI
2.6299-3.2579
-0.2972-0.1633
-0.1933-0.2628
-0.4166-0.0046
95% CI
-19.5868--2.2821
-0.7472-4.9880
-0.6304-0.4543
0.0433-0.3248

0.1317

-0.0828-0.0108

0.3982
0.2706
1.4716
0.1411
0.5097
0.2495
2.0433
0.0410
Direct and indirect effects
Effect
SE
z
p-value

-0.1321-0.9285
0.0208-0.9987
95% CI

Direct effect of
-0.0881
0.2767
-0.3183
0.7503
-0.6304-0.4543
X on Y
Conditional indirect effect of X on Y at values of the moderator
Mediator
Age
Effect
Boot SE
95% CI
Cancer fear
53
-0.0143
0.0460
-0.1962-0.0343
Cancer fear
57
-0.0046
0.0267
-0.1065-0.0248
Cancer fear
62
0.0074
0.0252
-0.0204-0.0998
Cancer fear
66
0.0171
0.0437
-0.0353-0.1641
Cancer fear
69
0.0243
0.0605
-0.0509-0.2202
Index of moderated mediation
Mediator
Index
Boot SE
Boot 95% CI
Cancer fear
0.0024
0.0061
-0.0050-0.0232
Note: N = 327.
The outcome variable, CRC screening adherence, was coded as 0 = no and 1 = yes.
Significant results are displayed in bold.
Coefficients are unstandardized.
SE = standard error; CI = confidence interval; CRC = colorectal cancer
1

Race coded as 0 = minority race and 1 = White race.

2

Education level coded as 0 = HS diploma or GED or less and 1 = some college or more.
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Table 10. Moderated mediation of relationship between self-reliance and colorectal
cancer screening adherence with race as moderator (Aim #3, Hypothesis #3.2)
Variable
Constant
Self-reliance
Age
Education level1
Variable
Constant
Trust in PCP
Self-reliance
Race2
Interaction (Trust
in PCP x Race)
Age
Education level1

Outcome: Trust in PCP
Coefficient
SE
t
p-value
4.7672
0.5636
8.4583
<0.01
-0.3143
0.1078
-2.9161 0.0038
-0.0040
0.0087
-0.4618 0.6445
0.0058
0.1043
0.0555
0.9558
Outcome: CRC screening adherence
Coefficient
SE
z
p-value
-4.2163
1.7993
-2.3433 0.0191
-0.0961
0.2811
-0.3418 0.7325
-0.4202
0.2677
-1.5696 0.1165
0.1388
1.3451
0.1032
0.9178
0.0766

0.3189

95% CI
3.6584-5.8760
-0.5264--0.1023
-0.0210-0.0130
-0.1994-0.2110
95% CI
-7.7430--0.6897
-0.6469-0.4548
-0.9450-0.1045
-2.4976-2.7752

0.2403

0.8101

-0.5484-0.7017

0.0831
0.0217
3.8342
0.5072
0.2467
2.0559
Direct and indirect effects
Effect
SE
z

0.0001
0.0398

0.0406-0.1256
0.0237-0.9907

p-value

95% CI

Direct effect of
-0.4202
0.2677
-1.5696 0.1165
-0.9450-0.1045
X on Y
Conditional indirect effect of X on Y at values of the moderator
Mediator
Race
Effect
Boot SE
95% CI
Trust in PCP
Black
0.0302
0.1154
-0.1577-0.3146
Trust in PCP
White
0.0061
0.0538
-0.0941-0.1267
Index of moderated mediation
Mediator
Index
Boot SE
Boot 95% CI
Trust in PCP
-0.0241
0.1268
-0.3176-0.2058
Note: N = 327.
The outcome variable, CRC screening adherence, was coded as 0 = no and 1 = yes.
Significant results are displayed in bold.
Coefficients are unstandardized.
PCP = primary care provider; SE = standard error; CI = confidence interval; CRC =
colorectal cancer
1

Education level coded as 0 = HS diploma or GED or less and 1 = some college or more.

2

Race coded as 0 = African American or Black race and 1 = White race
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Table 11. Moderated mediation of relationship between self-reliance and colorectal
cancer screening adherence with length in patient-provider relationship as moderator
(Aim #3, Hypothesis #3.3)
Variable
Constant
Self-reliance
Age
Race1
Education level2
Variable
Constant
Trust in PCP
Self-reliance
Length of relation.
Interaction (Trust
in PCP x Length)
Age
Race1
Education level2

Outcome: Trust in PCP
Coefficient
SE
t
p-value
4.7655
0.5644
8.4433
<0.01
-0.3104
0.1086
-2.8573 0.0046
-0.0036
0.0087
-0.4138 0.6793
-0.0372
0.1143
-0.3254 0.7451
0.0064
0.1045
0.0617
0.9509
Outcome: CRC screening adherence
Coefficient
SE
z
p-value
-3.9840
1.6426
-2.4254 0.0153
-0.1131
0.1939
-0.5834 0.5597
-0.3751
0.2657
-1.4119 0.1580
-0.0049
0.0151
-0.3250 0.7452
0.0017

0.0034

95% CI
3.6551-5.8759
-0.5241--0.0967
-0.0208-0.0136
-0.2620-0.1876
-0.1991-0.2120
95% CI
-7.2034--0.7646
-0.4932-0.2670
-0.8959-0.1456
-0.0345-0.0247

0.4839

0.6285

-0.0051-0.0084

0.0787
0.0218
3.6044
0.4269
0.2706
1.5776
0.4943
0.2473
1.9985
Direct and indirect effects
Effect
SE
z

0.0003
0.1146
0.0457

0.0359-0.1214
-0.1035-0.9573
0.0095-0.9791

p-value
95% CI
Direct effect of
-0.3751
0.2657
-1.4119 0.1580
-0.8959-0.1456
X on Y
Conditional indirect effect of X on Y at values of the moderator
Mediator
Length
Effect
Boot SE
95% CI
Trust in PCP
0
0.0351
0.0723
-0.0830-0.2189
Trust in PCP
10.51
0.0297
0.0627
-0.0735-0.1891
Trust in PCP
31.18
0.0190
0.0500
-0.0704-0.1381
Trust in PCP
78.92
-0.0057
0.0693
-0.1529-0.1366
Trust in PCP
118.14
-0.0260
0.1122
-0.2823-0.1883
Index of moderated mediation
Mediator
Index
Boot SE
Boot 95% CI
Trust in PCP
-0.0005
0.0013
-0.0036-0.0018
Note: N = 327
The outcome variable, CRC screening adherence, was coded as 0 = no and 1 = yes.
Significant results are displayed in bold.
Coefficients are unstandardized.
PCP = primary care provider; SE = standard error; CI = confidence interval; Length =
length of patient-provider relationship; CRC = colorectal cancer
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Table 11, continued.
1

Race coded as 0 = African American or Black race and 1 = White race.

2

Education level coded as 0 = HS diploma or GED or less and 1 = some college or more.
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Table 12. Logistic regression analyses predicting colorectal cancer screening adherence
as a function of masculinity norms (Aim 4)
Variables

B

Race1
-0.329
Age
0.085**
2
Education level
-0.413
Physician
-2.640**
3
recommend.
Family/friend
-0.403
recommend.4
Constant
-3.919**
1
Block Race
-0.411
2
Age
0.084**
Education level2
-0.436
Physician
-2.677**
recommend.3
Family/friend
-0.417
recommend.4
Heterosexual self- 0.258
present.
Self-reliance
-0.411
Risk-taking
0.176
Constant
-3.938*
Note: N = 327; *p < .05. **p < .01.
Block
1

.286
.023
.263
.570

Wald chisquare (df=1)
1.327
13.633
2.470
21.416

Odds
ratio
0.719
1.088
0.662
0.071

95% CI for
odds ratio
0.411-1.260
1.041-1.139
0.396-1.107
0.023-0.218

.260

2.393

0.668

0.401-1.113

1.426
.294
.023
.269
.574

7.553
1.946
13.034
2.620
21.712

0.020
0.663
1.087
0.647
0.069

0.372-1.181
1.039-1.138
0.382-1.096
0.022-0.212

.262

2.524

0.659

0.394-1.102

.207

1.548

1.294

0.862-1.943

.280
.300
1.574

2.154
0.344
6.262

0.663
1.192
0.019

0.383-1.148
0.663-2.144

SE

The outcome variable, CRC screening adherence, was coded as 0 = no and 1 = yes.
Significant results are displayed in bold.
Beta coefficients are unstandardized.
Table 12, continued.
SE = standard error; CI = confidence interval; CRC = colorectal cancer
1

Race coded as 0 = minority race and 1 = White race.

2

Education level coded as 0 = HS diploma or GED or less and 1 = some college or more.

3

Physician recommendation coded as 0 = no and 1 = yes.

4

Family/friend recommendation coded as 0 = no and 1 = yes.

B

SE

95% CI for
odds ratio

1.040-1.134
0.871-2.580
1.064-2.908
0.810-1.767
0.378-1.097
0.553-1.703

0.977-1.178
0.511-7.521
0.451-4.084
0.431-2.367
0.302-3.070
0.545-6.069

Odds
ratio

1.086
1.499
1.759
1.196
0.644
0.971

1.073
1.960
1.357
1.010
0.963
1.819

SE = standard error; CI = confidence interval

Beta coefficients are unstandardized.

Significant results are displayed in bold.

Receipt of colonoscopy and stool blood testing were each coded as 0 = no and 1 = yes.

Independent variable

Wald
(df=1)
Outcome: Receipt of colonoscopy
Intercept
1.487
10.815
-4.891**
Age
0.022
13.898
0.082**
1
Race
0.405
0.277
2.130
2
Education level
0.256
4.851
0.565*
Heterosexual self presentation 0.179
0.199
0.808
Self-reliance
-0.440
0.272
2.623
Risk-taking
-0.030
0.287
0.011
Outcome: Receipt of stool blood testing
Intercept
3.363
5.085
-7.584*
Age
0.071
0.048
2.186
Race1
0.673
0.686
0.962
2
Education level
0.305
0.562
0.294
Heterosexual self-presentation 0.010
0.434
0.001
Self-reliance
-0.037
0.591
0.004
Risk-taking
0.598
0.615
0.948
Note: N = 327; *p < .05, **p < .01.

Table 13. Multinomial logistic regression analyses predicting receipt of colonoscopy and stool blood testing (Aim 5)
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Race coded as 0 = minority race and 1 = White race.

Education level coded as 0 = HS diploma or GED or less and 1 = some college or more.

1

2

Table 13, continued.
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Table 14. Logistic regression analysis predicting endoscopic CRC screening as a function
of masculinity norms (modified Aim 5)
Variables

B

Block
1

Age
0.086**
1
Race
-0.306
Education level2
-0.550*
Constant
-4.469**
Block Age
0.086**
1
2
Race
-0.402
Education level2
-0.580*
Heterosexual self- 0.162
presentation
Self-reliance
-0.476
Risk-taking
-0.005
Constant
-4.069**
Note: N = 310. *p < .05. **p < .01.

Odds
ratio

95% CI for
odds ratio

0.022
0.270
0.251
1.371
0.022
0.279
0.257
0.199

Wald chisquare
(df=1)
15.159
1.291
4.819
10.623
14.540
2.071
5.103
0.668

1.090
0.736
0.577
0.011
1.089
0.669
0.560
1.176

1.044-1.139
0.434-1.249
0.353-0.943

0.275
0.284
1.506

2.987
0.000
7.300

0.621
0.995
0.017

0.362-1.066
0.570-1.737

SE

1.042-1.138
0.387-1.156
0.339-0.926
0.797-1.736

Endoscopic CRC screening coded as 0 = no and 1 = yes.
Significant results are displayed in bold.
Coefficients are unstandardized.
SE = standard error; CI = confidence interval; CRC = colorectal cancer
1

Race coded as 0 = minority race and 1 = White race.

2

Education level coded as 0 = HS diploma or GED or less and 1 = some college or more.

FIGURES
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Recruitment

Veterans approached in clinic
n = 561

Refused prior to eligibility
screening
n = 151
- Not interested: 139
- Study participation too much work: 9
- Too sick/Health reasons: 8
- Unable to complete paperwork/Possible
literacy issues: 5
- Prior bad CRC screening experience of
self/other: 5
- Concerns about privacy: 3
- Did not want to specify/No reason: 3
- In another study/Consider participation in
another study: 3
- Wouldn’t benefit individual himself: 2
- Dislikes surveys: 2
- No time: 2
- Other: 6

Eligibility

Veterans screened for eligibility
n = 410

Refused following screening
n=5
- Not interested: 4
- Concerns about privacy: 2

Veterans found to be
ineligible
n = 55
- Adherent to CRC screening guidelines prior
to change in eligibilty criteria: 15
- Cognitive issues: 14
- Literacy issues: 8
- FDR with diagnosis of early CRC: 6
- 2 or more FDRs with CRC: 6
- Personal history of CRC: 5
- Personal history of ulcerative
colitis/FAP/Lynch Syndrome: 3

Data collection

Veterans eligible and consented
n = 350
Veterans with incomplete data
n = 23

Data analysis

Figure 1. Study flowchart

Veterans with data utilized in
current study
n = 327
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Figure 1, continued.
Note: CRC = colorectal cancer; FDR = first degree relative; FAP = familial adenomatous
polyposis
Change in eligibility criteria during the course of the study: Originally, according to
eligibility criteria, only 150 individuals from each group (i.e., adherent and non-adherent
to CRC screening) were to be consented. However, due to low numbers of non-adherent
veterans, eligibility criteria were altered such that this criterion was omitted.
Veterans could indicate more than one reason for refusal and, thus, reason for refusal
totals do not equal the number of the individuals who refused to participate.
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Figure 2. Heterosexual self-presentation model
Note: Colorectal cancer screening status coded as 0 = no and 1 = yes.
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Figure 3. Risk-taking model
Note: Colorectal cancer screening status coded as 0 = no and 1 = yes.
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Figure 4. Self-reliance model
Note: Colorectal cancer screening status coded as 0 = no and 1 = yes.
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Figure 5. Risk-taking mediation model
Note: Colorectal cancer screening status coded as 0 = no and 1 = yes.
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Figure 6. Self-reliance mediation model
Note: Colorectal cancer screening status coded as 0 = no and 1 = yes.
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Figure 7. Risk-taking moderated mediation model
Note: Colorectal cancer screening status coded as 0 = no and 1 = yes.
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Figure 8. Self-reliance moderated mediation model #1
Note: Colorectal cancer screening status coded as 0 = no and 1 = yes. Race coded as 0 =
minority race and 1 = White race. Significant results are displayed in bold.
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Figure 9. Self-reliance moderated mediation model #2
Note: Colorectal cancer screening status coded as 0 = no and 1 = yes. PCP = primary
care provider. Significant results are displayed in bold.

APPENDICES
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Appendix A: Health Questions

1. Has a doctor ever told you that you had colon or rectal cancer?
Yes

No

2. Have any of your close blood relatives ever had colon or rectal cancer? By close
blood relatives, I mean your parents, brothers, sisters, or children.
Yes
No
3. If “yes” to question #2, how many of your close blood relatives (parents, sisters,
brothers, or children) have had cancer of the colon or rectum?
___________
4. If “yes” to question #2, did any of these relatives have cancer of the colon or
rectum before they were 60 years old?
Yes

No

5. Have you ever been told you have ulcerative colitis or Crohn's disease?
Yes

No

6. Have you ever been told you have Lynch syndrome or familial adenomatous
polyposis?
Yes

No

7. Has a doctor ever told you that you had colon or rectal polyps that were not
cancer?
Yes

Now there are some questions about colorectal cancer testing.

No
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The stool blood test, which is sometimes called a Hemoccult or fecal occult blood test or
fecal immunochemical test, is something you do at home to examine your stool for
hidden blood. The test requires you to place a small sample of your stool or bowel
movement on a special card that comes in a kit. This card is then sent to your doctor’s
office or to a lab for testing.
8. Have you done a stool blood test at home and mailed or brought the cards back to
your doctor’s office or a lab in the past 12 months?
Yes
No
During a sigmoidoscopy, a doctor inserts a thin, flexible tube with a light into your
rectum to examine your colon for any unusual growths. The tube is shorter than the one
used for a colonoscopy and does not allow the doctor to see as much of your colon. You
rarely need medicine to help you relax for this test. The test usually takes about 15
minutes.
9. Have you had a sigmoidoscopy in the past 5 years?
Yes

No

A colonoscopy is a test where a doctor inserts a thin, flexible tube with a light into your
rectum to examine your colon for any unusual growths. Right before the test, you get
some medicine to help you relax. The test usually takes 30 to 60 minutes, depending on
whether there are growths or polyps that need to be removed. Afterward, you wait for
the relaxing medicine to wear off, and someone has to drive you home.
10. Have you had a colonoscopy in the past 10 years?
Yes

THANK YOU FOR YOUR PARTICIPATION!

No
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Appendix B: Health Experiences

1. Have you ever been diagnosed with a cancer other than colon, rectal, or skin
cancers?
Yes

No

Yes

No

2. Have any of your friends or co-workers had colon or rectal cancer?

3. Have any of your distant blood relatives had colon or rectal cancer? This would
include your grandparents, aunts, uncles, or cousins.
Yes

No

4. Have any family members or friends encouraged you to have a colon test?
Yes

No

Now there are some questions about the stool blood test, which is sometimes called a
Hemoccult or fecal occult blood test or fecal immunochemical test. This is
something you do at home to examine your stool for hidden blood. The test requires
you to place a small sample of your stool or bowel movement on a special card that
comes in a kit. This card is then sent to your doctor’s office or to a lab for testing.
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5. Has a doctor ever recommended that you do a stool blood test?
Yes

No

6. Have you ever done a stool blood test at home and mailed or brought the cards back
to your doctor’s office or a lab?

Yes

No

7. If yes to question #6, when did you do your most recent stool blood test at home?
Month: ____________________

Year: ________________

8. If yes to question #6, did you send your most recent stool blood test to the VA?
Yes

No

During a sigmoidoscopy, a doctor inserts a thin, flexible tube with a light into your
rectum to examine your colon for any unusual growths. The tube is shorter than the one
used for a colonoscopy and does not allow the doctor to see as much of your colon. You
rarely need medicine to help you relax for this test. The test usually takes about 15
minutes.

9. Has a doctor ever recommended you have a sigmoidoscopy?

Yes

No

10. Have you ever had a sigmoidoscopy?

Yes

No
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11. If yes to question #10, when was your most recent sigmoidoscopy?
Month: ____________________

Year: ________________

12. If yes to question #10, was your most recent sigmoidoscopy completed at the VA?
Yes

No

A colonoscopy is a test where a doctor inserts a thin, flexible tube with a light into your
rectum to examine your colon for any unusual growths. Right before the test, you get
some medicine to help you relax. The test usually takes 30 to 60 minutes, depending on
whether there are growths or polyps that need to be removed. Afterward, you wait for
the relaxing medicine to wear off, and someone has to drive you home.

13. Has a doctor ever recommended you have a colonoscopy?

Yes

No

14. Have you ever had a colonoscopy?

Yes

No

15. If yes to question #14, when was your most recent colonoscopy?
Month: ____________________

Year: ________________

16. If yes to question #14, was your most recent colonoscopy completed at the VA?
Yes

No
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Note: The instructions for the Trust in Physician measure and all 5 items of the
Trust in Physician measure were located here in the study questionnaire.

Note: The instructions for the Conformity to Masculine Norms meaure and all 46
items of the Conformity to Masculine Norms Inventory were located here in the
study questionnaire.

Note: The instructions for the Cancer Fear measure and all 8 items of the Cancer
Fear measure were located here in the study questionnaire.

General Information

1. Age: ___________ years

2. What race or ethnicity do you consider yourself to be?
___Black or African American
___Native American

___White

___Asian-American or Pacific Islander

___Hispanic or Latino

___Other (please

specify)__________________________

3. Marital Status (check one) ___Single
___Married

___Separated

___Living with partner
___Divorced

___Widowed
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4. Employment status (check one) ___Employed full-time
___Employed part-time

___Student

___Unemployed, looking for work

___Homemaker

___Retired

___Unemployed, due to disability

___Other (please specify) ______________________________

5. What is the highest grade or year of school you completed?
___Never attended school or only attended kindergarten
___Grades 1 through 8 (Elementary)
___Grades 9 through 11 (Some high school)
___Grade 12 or GED (High school graduate)
___College 1 year to 3 years (Some college or technical school)
___ College 4 years or more (College graduate)
___Graduate school (Master’s degree, Doctorate, etc.)

6. Do you have health insurance coverage now (outside of VA benefits)?
Yes

7. What is your combined yearly household income before taxes?
___ $0-$10,999

___$11,000-$20,999

___$31,000-$50,999 ___$51,000 to $99,999

THANK YOU FOR YOUR PARTICIPATION!

___$21,000-$30,999
___$100,000 or more

No

VITA
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September). Predictors of colorectal cancer screening discussions between Black
primary care patients and their providers. Paper presented at the 2012 National State of
the Science Congress on Nursing Research, Washington, D.C.
9. Rawl, S.M., Perkins, S., Tong, Y., Krier, C., Christy, S., Wang, H-L., Champion,
V.L., Springston, J., & Skinner, C.S. (2012, September). Increasing colorectal cancer
screening in low-income Black primary care patients: 6 month results of a randomized
trial. Poster presented at the 2012 National State of the Science Congress on Nursing
Research, Washington, D.C.
10. Wang, H-L., Skinner, C.S., Champion, V.L., Springston, J., Perkins, S., Tong, Y.,
Krier, C., Gebregziabher, N., Christy, S., & Rawl, S.M. (2012, September). Factors
predicting stage of adoption for fecal occult blood testing and colonoscopy among nonadherent African Americans. Paper presented at the 2012 National State of the Science
Congress on Nursing Research, Washington, D.C.
11. Christy, S.M., Mosher, C.E., Lipkus, I., Sloane, R., Snyder, D.C., Lobach, D.F., &
Demark-Wahnefried, W. (2012, June). Long-term outcomes of the FRESH START trial:
Exploring the role of self-efficacy in cancer survivors’ maintenance of dietary practices
and physical activity. Poster presented at the 2012 Biennial Cancer Survivorship
Conference, Arlington, VA.
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12. Wang, H-L., Skinner, C.S., Champion, V.L., Springston, J., Perkins, S., Tong, Y.,
Krier, C., Gebregziabher, N., Christy, S., & Rawl, S.M. (2012, May). Colorectal cancer
screening in non-adherent Black Americans. Poster presented at the 2012 Cancer,
Culture & Literacy Conference, Clearwater Beach, FL.
13. Christy, S.M., Perkins, S., Tong, Y., Gebregziabher, N., Krier, C., Champion, V.,
Skinner, C.S., Springston, J., Rhyant, B., Imperiale, T., & Rawl, S. (2012, April).
Predictors of colorectal cancer screening discussions between African-American
patients and their providers. Poster presented at the 2012 Annual Meeting of the Society
of Behavioral Medicine, New Orleans, LA.
14. Christy, S.M., Mosher, C.E., Sloane, R., Snyder, D.C., Lobach, D., & DemarkWahnefried, W. (2011, April). Long-term dietary outcomes of the FRESH START
intervention for breast and prostate cancer survivors. Poster presented at the 2011
Annual Meeting of the Society of Behavioral Medicine, Washington, D.C.
Local Presentations:
15. Christy, S.M., Brittain, K., & Rawl, S.M. (2014, May). African American patients’
intent to screen for colorectal cancer: Do cultural factors, health literacy, knowledge,
age and gender matter? Poster presented at the 2014 Indiana University Simon Cancer
Center Cancer Research Day, Indianapolis, IN.
16. Winger, J.G., Christy, S.M., & Mosher, C.E. (2014, May). Health behaviors
associated with HPV vaccine receipt and intentions among undergraduate women.
Poster presented at the 2014 Indiana University Simon Cancer Center Cancer Research
Day, Indianapolis, IN.
17. Van Antwerp, L.R., Christy, S.M., Mosher, C.E., Rawl, S.M., & Haggstrom, D.A.
(2014, April). Predictors of colorectal cancer screening adherence among male
veterans. Poster presented at the 2014 IUPUI Research Day, Indianapolis, IN.
18. Christy, S.M., Wang, H., Perkins, S.M., Tong, Y., Champion, V.L., Krier, C., Myers,
L.J., Imperiale, T., Skinner, C.S., & Rawl, S.M. (2013, May). Change in stage of
adoption following two colorectal cancer screening interventions. Poster presented at the
2013 Indiana University Simon Cancer Center Cancer Research Day, Indianapolis, IN.
19. Christy, S.M., Wang, H., Perkins, S.M., Tong, Y., Champion, V.L., Krier, C., Myers,
L.J., Imperiale, T., Skinner, C.S., & Rawl, S.M. (2013, May). Change in stage of
adoption following two colorectal cancer screening interventions. Poster presented at the
2013 Richard L. Roudebush VAMC 4th Annual Scientific Symposium, Indianapolis, IN
(presented by C. Krier).
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(2013, April). Interventions to promote colorectal cancer screening in primary care:
Results of a randomized trial. Poster presented at the 2013 IUPUI Research Day,
Indianapolis, IN.
21. Van Antwerp, L.R., Winger, J.G., Christy, S.M., & Mosher, C.E. (2013, April).
Relationships between health behaviors and HPV vaccine receipt and intentions among
undergraduate women. Poster presented at the 2013 IUPUI Research Day, Indianapolis,
IN.
22. Christy, S.M., Perkins, S., Tong, Y., Gebregziabher, N., Krier, C., Champion, V.,
Skinner, C.S., Springston, J., Rhyant, B., Imperiale, T., & Rawl, S. (2012, May).
Predictors of colorectal cancer screening discussions between African-American
patients and their providers. Poster presented at the 2012 Indiana University Simon
Cancer Center Cancer Research Day, Indianapolis, IN.
23. Christy, S.M., Perkins, S., Tong, Y., Gebregziabher, N., Krier, C., Champion, V.,
Skinner, C.S., Springston, J., Rhyant, B., Imperiale, T., & Rawl, S. (2012, April).
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patients and their providers. Poster presented at the 2012 Richard L. Roudebush VAMC
4th Annual Scientific Symposium, Indianapolis, IN.
______________________________________________________________________
RESEARCH EXPERIENCE
______________________________________________________________________
Co-investigator and Research Team Member, October 2011-July 2015
Colonoscopy Scheduled and Subsequent Test (COAST) Research Team
School of Nursing
Indiana University, Indianapolis, Indiana
Duties:

Co-designed mixed methods study; co-wrote Abstract, Specific
Aims, and Approach sections of successful grant application for pilot
study funding; attend research team meetings; perform qualitative
data coding.

Supervisor:

Susan M. Rawl, PhD, RN, FAAN
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Research Team Member, July 2011-July 2015
Promoting African American Colon Testing (PACT) Research Team
School of Nursing
Indiana University, Indianapolis, Indiana
Duties:

Conduct data analyses and prepare manuscripts; attend research
team meetings.

Supervisor:

Susan M. Rawl, PhD, RN, FAAN

Graduate Research Assistant, August 2010-June 2014
Department of Psychology
Indiana University-Purdue University Indianapolis, Indianapolis, Indiana
Duties:

Recruited participants and conducted assessments for NCI-funded
research on the support needs and preferences of lung cancer patients
and their caregivers; co-designed studies on HPV vaccination
acceptance and other health behaviors; conducted literature searches
and compiled measures; conducted data analyses and prepared
manuscripts; trained, mentored, and supervised undergraduate research
assistants; collected information from medical records; maintained
study databases and participant files; assisted with intervention design
and grant preparation; provided training in clinical skills and medical
chart data extraction to research assistants and trial therapists.

Supervisor:

Catherine E. Mosher, PhD

Data Manager, August 2009-January 2010
Department of Counseling Psychology
Ball State University, Muncie, Indiana
Duties:

Assisted with data entry and organization for a doctoral student’s
dissertation entitled, The moderating and mediating effects of
religious coping on quality of life in long-term survivors of cancer.

Supervisor:

Sarah Jenkins, MA, Doctoral Candidate
Donald Nicholas, PhD, HSPP
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Student Researcher, August 2007-July 2010
Health Psychology Research Team
Department of Counseling Psychology
Ball State University, Muncie, Indiana
Duties:

Assisted other student researchers through survey preparation and
data entry; discussed research methods; assisted in data collection
for meta-analysis.

Supervisor:

Donald Nicholas, PhD, HSPP

Undergraduate Research Assistant, August 2002-May 2003
Department of Psychology
Miami University, Oxford, Ohio
Duties:

Mentored independent study experience in APA-style manuscript
writing.

Supervisor:

Z. Michael Nagy, PhD

______________________________________________________________________
CLINICAL EXPERIENCE
______________________________________________________________________
Clinical Health Psychology Intern, July 2014-June 2015
VA Connecticut Healthcare System-West Haven campus
West Haven, Connecticut
Integrated Primary Care Clinic (August 2014-June 2015):
Duties:
Conduct time-limited, evidence-based individual psychotherapy
(e.g., Cognitive-Behavioral Therapy, Motivational Interviewing) and
assessments with veterans presenting with a wide range of comorbid physical and psychological diagnoses in order to improve
health behaviors and medical self-management strategies and to
facilitate coping with medical diagnoses as well as prevention of
chronic illnesses. Work within a multidisciplinary team of medical
care providers. Serve in a consultation role to other medical care
providers to improve patient care.
Supervisors: Jessica Barber, PhD, Laura Blakley, PhD, Caroline Schmidt, PhD and John
Sellinger, PhD
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Cancer Center (January 2015- June 2015):
Duties:
Conduct assessments and provide individual and group therapy to
individuals facing a hematology or oncology diagnosis. Conduct
evaluations for bone marrow transplantation.
Supervisor: Jessica Barber, PhD
Integrated Pain Clinic (August 2014-December 2014):
Duties:
Conduct cognitive-behavioral assessments with veterans with pain
conditions in order to determine the biological, psychological, and
social contributors to their pain experience. Work within a
multidisciplinary team which includes psychology, pain medicine,
physiatry, physical therapy, pharmacy, and substance abuse
treatment professionals in order to provide a comprehensive pain
evaluation and develop a pain management plan and
recommendations.
Supervisor: John Sellinger, PhD
Preceptor: Laura Wandner, PhD
Inpatient Consultation-Liaison Service (July 2014- June 2015):
Duties:
Conduct assessments and provide psychotherapy to individuals who
are currently inpatient in a variety of medical and surgical units
within the medical center. Serve as a consultant and make
recommendations to medical staff surrounding patients’
psychosocial functioning and coping.
Supervisors: Jessica Barber, PhD, Laura Blakley, PhD, Caroline Schmidt, PhD, and John
Sellinger, PhD
Preceptor: Kristina Schumann, PhD
Clinical Health Psychology Assessment Clinic (August 2014- June 2015):
Duties:
Conduct evaluation and participate in treatment planning for
individuals diagnosed with a variety of co-morbid physical and
psychological diagnoses. Write reports following clinical interview
and psychological evaluation for organ transplantation.
Supervisor: Jessica Barber, PhD
Preceptors: Aaron Martin, PhD and Noel Quinn, PhD
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Smoking Cessation Clinic (August 2014-November 2014):
Duties:
Co-facilitate smoking cessation group by providing psychoeducation
around smoking cessation strategies through Cognitive-Behavioral
and Motivational Interviewing techniques.
Supervisor: Lisa Frantsve, PhD
Preceptor: Anthony Brinn, PsyD
Weight Management Clinic (July 2014-October 2014 and March 2015- June 2015):
Duties:
Co-facilitate the Managing Overweight/Obese Veterans Everywhere
(MOVE!) weight management groups with colleagues from the
physical therapy and nutrition services. Provide psychoeducation
surrounding behavioral and cognitive weight management strategies.
Supervisor: Lindsey Dorflinger, PhD
Preceptor: Leila Islam, PhD
Interdisciplinary Stroke Clinic (November 2014-February 2015):
Duties:
Conduct assessments with individuals who have suffered a stroke or
other cerebrovascular injury in order to identify risk factors for
subsequent brain injuries. Work within an interdisciplinary team of
neurology, pharmacy, physical therapy, and psychology in order to
make recommendations for behavioral change to reduce secondary
stroke risk.
Supervisor: Valerie Weisser, PhD
Palliative Care (March 2015- June 2015):
Duties:
Provide supportive therapy and conduct assessments with
individuals who are receiving inpatient palliative care services in a
variety of medical and surgical units. Serve as a consultant and
make recommendations to medical staff surrounding patients’
psychosocial functioning and coping.
Supervisor: Laura Blakely, PhD
Audiology Clinic (March 2015- June 2015):
Duties:
Co-facilitate Cognitive-Behavioral Therapy-based tinnitus
management group and conduct cochlear implant evaluations.
Supervisor: Caroline Schmidt, PhD
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Practicum Student, January 2013-April 2013
Richard L. Roudebush VA Medical Center
Indianapolis, Indiana
Duties:
Conducted neuropsychological and personality assessments with
veterans with a variety of referral questions including traumatic
brain injuries, compensation and pension evaluations, dementia, and
severe mental illness. Wrote integrated reports based upon clinical
interview and assessment results.
Supervisor:

Kriscinda Whitney, PhD, HSPP

Peer Supervisor, September 2012-May 2013
Indiana University-Purdue University Indianapolis, Department of Psychology
Indianapolis, Indiana
Duties:

Provided peer supervision to Clinical Psychology PhD students who
were earlier in their practica careers.

Supervisor:

John Guare, PhD, HSPP

Practicum Student, August 2012-December 2012
Larue D. Carter Memorial Hospital
Indianapolis, Indiana
Duties:

Provided group and individual therapy (Cognitive-Behavioral Therapy,
Dialectical Behavioral Therapy, Behavioral Therapy) to adult patients
in an inpatient setting. Co-led Borderline Personality Disorder and
Transition Skills groups. Conducted assessments with individuals
diagnosed with severe mental illnesses.

Supervisor:

Kristine M. Chapleau, PhD, HSPP
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Practicum Student, August 2011-April 2012
Richard L. Roudebush VA Medical Center
Indianapolis, Indiana
Duties:

Provided individual and group therapy (Cognitive-Behavioral
Therapy, Cognitive Processing Therapy, Acceptance and
Commitment Therapy, Motivational Interviewing) to adult clients in
an integrated primary care setting. Led Chronic Pain Management
and Managing Overweight/Obese Veterans Everywhere (MOVE!)
Level 2 weight management groups. Conducted mood, personality,
intelligence, and neuropsychological assessments. Wrote integrated
reports following clinical interview and psychological evaluation for
Interferon treatment and Spinal Cord Stimulator implants.

Supervisor:

Jennifer Lydon-Lam, PhD, HSPP

Practicum Student, April 2011-August 2011
Adult Outpatient Clinic, Department of Psychiatry, Indiana University School of
Medicine, University Hospital
Indiana University Simon Cancer Center
Indianapolis, Indiana
Duties:

Provided individual therapy (Cognitive-Behavioral Therapy,
Acceptance and Commitment Therapy) to cancer patients and family
caregivers at Indiana University Simon Cancer Center. Provided
individual therapy (Cognitive-Behavioral Therapy, Acceptance and
Commitment Therapy) to adult clients at Adult Outpatient Clinic.

Supervisor:

Natalie Dattilo, PhD, HSPP

Interim Program Director, May 2010-June 2010
Cancer Support Community, formerly The Wellness Community of Central Indiana
Indianapolis, Indiana
Duties:

Led bi-weekly Facilitator Supervision meetings for LCSW and
LFMT staff; created, designed, and planned program calendar and
secured speakers for programs; served as point person for individuals
interested in programming; maintained program statistics and
completed various administrative tasks; created upcoming program
marketing materials; trained incoming Program Director; co-organized
Survivors Symposium 2010 and served as moderator of Survivor Panel
at Survivors Symposium 2010.
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Clinical Program Intern, August 2009-May 2010
Cancer Support Community, formerly The Wellness Community of Central Indiana
Indianapolis, Indiana
Duties:

Conducted cancer patient and caregiver support groups and intake
interviews; engaged in public outreach and programming;
maintained program statistics; provided individual counseling;
fulfilled Program Director tasks while Program Director was on
maternity leave from September through December 2009.

Supervisors:

Alan Maugherman, PhD, HSPP
Janet Wilson, MSW, LCSW
Laura Weiger, MSW, LCSW

Counselor in training, May 2009-July 2009
Ball State University Counseling Practicum Clinic
Muncie, Indiana
Duties:

Provided individual and family counseling (Interpersonal Therapy,
Cognitive-Behavioral Therapy) to the public.

Supervisors:

Donald Nicholas, PhD, HSPP
Kristen Jones, MA

Counselor in training, May 2009-July 2009
Ball State University Wellness Group
Muncie, Indiana
Duties:

Co-led psycho-educational group for older adults on health-related
and psychosocial topics in residential setting.

Supervisors:

Donald Nicholas, PhD, HSPP
Summer Ibarra, MA
Aarika Vannatter, MA

Counselor in training, January 2009-May 2009
Wilson Middle School
Muncie, Indiana
Duties:

Provided individual, family, and group counseling to students and
their parents (Interpersonal Therapy, Cognitive-Behavioral Therapy).

Supervisors:

Alan Maugherman, PhD, HSPP
Jennifer Walsh, MA

159
Rape Victim Advocate, October 2002-April 2013
Butler County Crisis & Counseling Center
Oxford, Ohio
Duties:

Provided emotional support and information to rape victims via phone
and face-to-face contact as volunteer advocate.

Supervisor:
Jennifer Weigel, MSW, LISW
______________________________________________________________________
MENTORING AND TEACHING EXPERIENCE
______________________________________________________________________
Presentation and co-facilitation of Cognitive Behavioral Therapy Skills Training for
Yale University School of Medicine Primary Care Residents, March 2015, St. Raphael’s
Hospital, New Haven, Connecticut
Presented “Personality” guest lecture to undergraduate Introduction to Psychology class,
October 2014, University of New Haven, West Haven, Connecticut
Assisted with design and facilitation of Cognitive Behavioral Therapy Skills Training for
Yale University School of Medicine Primary Care Residents, October 2014, St.
Raphael’s Hospital, New Haven, Connecticut
Presented “Anxiety Disorders” guest lecture to undergraduate Abnormal Psychology
class, September 2014, University of New Haven, West Haven, Connecticut
Mentored undergraduate Psychology student throughout Honor’s thesis project and
Capstone course, July 2013-May 2014, IUPUI, Indianapolis, Indiana
Mentored undergraduate Psychology student’s successful Undergraduate Research
Opportunities Program Project grant application entitled “Predictors of Colorectal
Cancer Screening Adherence among Male Veterans” awarded by the IUPUI Center for
Research and Learning, August 2013-December 2013, IUPUI, Indianapolis, Indiana
Completed the “Seminar in Teaching Psychology” course, May 2012-July 2012, IUPUI,
Indianapolis, Indiana
______________________________________________________________________
PROFESSIONAL MEMBERSHIPS
______________________________________________________________________
American Society of Preventive Oncology, January 2013-Present, Student member
American Psychological Association Division 51: Society for the Psychological Study of
Men and Masculinity, January 2013-December 2014, Student member
American Psychological Association Division 12: Clinical Psychology, May 2012December 2013, Student member
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Society of Behavioral Medicine, September 2010-Present, Student member
American Psychological Association Division 38: Health Psychology, 2010, 2012Present, Student member
Ball State University Social Justice League, May 2009-July 2010
American Psychological Association, September 2007-Present, Student member
(APAGS member)
Psychology Club, September 2002-May 2003, Miami University
______________________________________________________________________
EDITORIAL ACTIVITIES
______________________________________________________________________
Mentored Ad Hoc Manuscript Reviews:
Psycho-Oncology (x2)
Social Science Research
Journal of Consulting and Clinical Psychology
______________________________________________________________________
WORKSHOPS ATTENDED
______________________________________________________________________
Motivational Interviewing for PACT Clinicians, September 2014
Presenters: Lindsey Dorflinger, PhD, Clinical Psychologist, Health Behavior
Coordinator, VA Connecticut Healthcare System, Department of
Psychiatry, Yale University School of Medicine
Jacquelyn Wolf MSN, RN, CDE, Health Promotion, Disease Prevention
Coordinator, VA Connecticut Healthcare System
Location: VA Connecticut Healthcare System, Newington, Connecticut
Biofeedback for Pain Management, April 2014
Presenter: Eric Scott, PhD, HSPP, Assistant Professor of Clinical Psychology in
Clinical Psychiatry, Indiana University
Location: Indiana University-Purdue University Indianapolis, Indianapolis, Indiana
Mixed Methods in the Social, Behavioral, Health Sciences and STEM Fields, February
2014
Presenter: John W. Creswell, PhD, Professor of Educational Psychology, University
of Nebraska-Lincoln; Visiting Professor, School of Public Health, Harvard
University
Location: Indiana University-Purdue University Indianapolis, Indianapolis, Indiana
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Consultation Workshop, October 2013
Presenter: Susan Hickman, PhD, Associate Professor, Indiana University School of
Nursing
Location: Indiana University-Purdue University Indianapolis, Indianapolis, Indiana
Scientific Writing from the Reader’s Perspective, July 2013
Presenter: George Gopen, JD, PhD, Professor, Duke University
Location: Indiana University-Purdue University Indianapolis, Indianapolis, Indiana
Self-Hypnosis for Chronic Pain Management, April 2013
Presenter: Mark Jensen, PhD, Professor, University of Washington
Location: Indiana University-Purdue University Indianapolis, Indianapolis, Indiana
Consultation Workshop: Focus on Fidelity and Feedback, January 2013
Presenter: Angela Rollins, PhD, Roudebush Veterans Affairs Medical Center
Location: Indiana University-Purdue University Indianapolis, Indianapolis, Indiana
Write Winning Grant Proposals, October 2012
Presenter: John Robertson, PhD, Grant Writers’ Seminars & Workshops
Location: Indiana University-Purdue University Indianapolis, Indianapolis, Indiana
Overview of Mental Health and Behavioral Consultation, October 2011
Presenter: Lisa Ruble, PhD, Associate Professor of Educational Psychology,
University of Kentucky
Location: Indiana University-Purdue University Indianapolis, Indianapolis, Indiana
Group Schema Therapy Workshop, March 2011
Presenters: Joan Farrell, PhD, Adjunct Professor, Indiana University School of
Medicine, Department of Psychiatry and Training Director of the Center for
Borderline Personality Disorder Treatment & Research; Ida Shaw, M.A.,
Director of BASE Consulting Group
Location: Indiana University-Purdue University Indianapolis, Indianapolis, Indiana
______________________________________________________________________
WORK EXPERIENCE
______________________________________________________________________
Museum Administrator, January 2004-January 2009
Indiana Landmarks, formerly Historic Landmarks Foundation of Indiana
Indianapolis, Indiana
Duties:

Gave invited podium presentations at Association of American
Museums conference in 2005 and Association of Indiana Museums
conference in 2006; performed budget planning and maintenance
duties; completed grant writing and fund-raising duties; performed
public speaking tasks including television interviews; executed all
duties described below in Program Manager position.

162

Program Manager, July 2003-December 2003
Indiana Landmarks, formerly Historic Landmarks Foundation of Indiana
Indianapolis, Indiana
Duties:

Engaged in exhibit and program research, planning, and production;
performed public speaking tasks through guided tours, education and
special event program presentation, and radio programming;
mentored undergraduate and graduate Public History and Museum
Studies student interns; engaged in frequent contact with the public,
volunteers, interns, advisory committee members, and board
members.
______________________________________________________________________
SERVICE ACTIVITIES
______________________________________________________________________
University Service:
Campus Representative for American Psychological Association, Society of Clinical
Psychology (Division 12), May 2012-December 2013
Indiana University-Purdue University Indianapolis
Indianapolis, Indiana
Campus Representative for American Psychological Association of Graduate Students
Advocacy Coordinating Team (ACT), September 2010-September 2011
Indiana University-Purdue University Indianapolis
Indianapolis, Indiana
Social Justice League Website Committee Member, February 2010-July 2010
Ball State University
Muncie, Indiana
Graduate Studies Committee member, September 2009-July 2010
Department of Counseling Psychology
Ball State University
Muncie, Indiana
Community Service:
American Cancer Society, 2011
2011 Relay for Life Team Co-Captain
Indianapolis, Indiana
Board of Directors Member, October 2007-January 2009
Secretary of the Board
Chair of the Nominating Committee
Association of Indiana Museums
Indianapolis, Indiana
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Board of Directors Member, May 2007-July 2008
Old Centrum Foundation
Indianapolis, Indiana

